Page last updated: 2024-09-04

docetaxel anhydrous and Neutropenia

docetaxel anhydrous has been researched along with Neutropenia in 508 studies

Research

Studies (508)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	51 (10.04)	18.2507
2000's	241 (47.44)	29.6817
2010's	190 (37.40)	24.3611
2020's	26 (5.12)	2.80

Authors

Authors	Studies
Hirahara, N; Hyakudomi, R; Ishitobi, K; Kaji, S; Matsubara, T; Tajima, Y; Takai, K; Uchida, Y; Yamamoto, T	1
Antonuzzo, L; Brugia, M; De Vita, F; Di Donato, S; Fancelli, S; Formica, V; Fornaro, L; Giommoni, E; Giovanardi, F; Iachetta, F; Lavacchi, D; Pecora, I; Pillozzi, S; Pompella, L; Pozzo, C; Prisciandaro, M; Puzzoni, M; Romagnani, A; Satolli, MA; Sisani, M; Spallanzani, A; Stragliotto, S; Strippoli, A; Tirino, G	1
Hikita, K; Honda, M; Iwamoto, H; Kawamoto, B; Morizane, S; Shimizu, R; Takenaka, A; Teraoka, S; Yamaguchi, N; Yumioka, T	1
Daiko, H; Demachi, K; Fujii, S; Itoh, K; Kawasaki, T; Kojima, T; Nomura, H; Tsuji, D; Ueno, S; Yano, T	1
Byeon, S; Jeon, HG; Jeon, SS; Kim, H; Lee, HM; Lee, SI; Park, SH; Seo, SI	1
Adamchuk, H; Blayney, DW; Chen, M; Du, L; Ginn, G; Huang, L; Kirtbaya, DV; Mohanlal, R; Ogenstad, S; Zhang, Q	1
Alekseev, B; Crawford, ED; Cruz, F; Fizazi, K; Fu, C; Hussain, M; Joensuu, H; Kopyltsov, E; Kuss, I; Li, R; Maughan, BL; Méndez-Vidal, MJ; Montesa-Pino, Á; Park, CH; Parnis, F; Saad, F; Smith, MR; Sternberg, CN; Suzuki, H; Tammela, TLJ; Thiele, S; Tombal, B; Uemura, M; Utriainen, T; Ye, D	1
Inaki, N; Kinoshita, J; Moriyama, H; Nakamura, K; Ninomiya, I; Okamoto, K; Saito, H; Shimada, M; Terai, S; Yamaguchi, T	1
Atsuta, M; Egawa, S; Enei, Y; Habuchi, T; Hata, K; Hatakeyama, S; Kimura, T; Kondo, Y; Mori, K; Narita, S; Obayashi, K; Oguchi, T; Ohyama, C; Sadakane, I; Shariat, SF; Yanagisawa, T; Yoshihara, K	1
Guo, Z; Lu, X; Qin, L; Wang, H; Wu, J; Yang, F; Yang, N	1
Amrita, PNA; Ashariati, A; Bintoro, UY; Diansyah, MN; Hendrata, WM; Looi, SS; Mahmudin, AA; Romadhon, PZ; Savitri, M; Wijaya, AY	1
Asano, F; Hayashi, T; Hirashita, T; Inoue, K; Ito, K; Katagiri, N; Mano, S; Masuda, A; Miyazaki, K; Oguri, R; Ohno, H; Sekiya, Y; Tsuzuku, A	1
Åström, L; Attard, G; Boysen, G; Bracarda, S; Chowdhury, S; Esen, A; Feyerabend, S; Gourgioti, G; López-Brea Piqueras, M; Martins, K; Matveev, VB; Merseburger, AS; Senkus, E	1
Asahina, S; Choi, G; Choi, SJ; Choy, JH; Jin, GW; Lee, HJ; Piao, H; Rejinold, NS	1
Chen, Q; Chen, Y; Guo, J; Li, X; Lin, J; Lin, M; Lin, W; Weng, Y; Yu, X; Zeng, S; Zheng, X	1
Akimoto, S; Fujita, M; Goto, A; Inaba, K; Matsuoka, H; Nakamura, K; Nakauchi, M; Serizawa, A; Shibasaki, S; Suda, K; Tanaka, T; Umeki, Y; Uyama, I	1
Cao, Y; Gong, J; Kou, F; Li, J; Li, Y; Liu, D; Lu, M; Lu, Z; Shen, L; Wang, X; Wang, Z; Xu, R; Zhang, X; Zhou, J; Zhu, X; Zou, J	1
Ah, YM; Cha, SH; Choi, HD; Shin, KH	1
Barwad, A; Bhatnagar, S; Bhoriwal, S; Dhamija, E; Kumar, A; Mridha, AR; Rastogi, S; Shamim, SA; Tansir, G	1
Atagi, S; Daimon, T; Kawahara, M; Kim, YH; Komuta, K; Minato, K; Okano, Y; Okishio, K; Tabata, C; Tamura, A; Usui, R	1
Dohi, O; Fujiwara, H; Ishikawa, T; Itoh, Y; Kamada, K; Konishi, H; Naito, Y; Okayama, T; Shiozaki, A; Takagi, T; Teramukai, S; Uchiyama, K; Yasuda, T; Yoshida, N	1
Aalbers, A	1
Bhat, G; Chawla, S; Cobb, PW; Hasal, SJ; Láng, I; Mezei, K; Moon, YW; Schwartzberg, LS	1
Daiko, H; Demachi, K; Fujii, S; Itoh, K; Kawasaki, T; Kojima, T; Matsuzawa, H; Mochizuki, N; Nomura, H; Tsuji, D; Yano, T	1
Barrett, JA; Chawla, S; Greene, D; Kolli, P; Lakshmikanthan, S; Lebel, F	1
Barrett, JA; Choi, IY; Choi, J; Greene, D; Kim, YH; Kim, YY; Kolli, P; Lakshmikanthan, S; Lebel, F; Song, TH	1
Aarons, L; Lombard, A; Mistry, H; Ogungbenro, K	1
Ando, T; Fujii, H; Hamamoto, Y; Hara, H; Hosokawa, A; Ishikawa, H; Katada, C; Koizumi, W; Kojima, T; Muto, M; Nakajima, TE; Sakamoto, Y; Sugawara, M; Tahara, M; Watanabe, A	1
Miwa, Y; Naito, M; Shimamoto, C; Yamamoto, T	1
Chiba, N; Imai, H; Ishioka, C; Komine, K; Mori, T; Ohori, H; Okada, Y; Saijo, K; Shimodaira, H; Shirota, H; Takahashi, M; Takahashi, S	1
Mahdi, H; Maurer, K; Michener, C; Rose, PG	1
Fujiuchi, N; Hasebe, T; Hirokawa, E; Matsuura, K; Misumi, M; Osaki, A; Saeki, T; Sakurai, T; Shigekawa, T; Shimada, H; Sugitani, I; Takahashi, T; Takeuchi, H; Ueda, S	1
Akita, H; Fujiwara, Y; Kobayashi, S; Miyata, H; Miyoshi, N; Motoori, M; Ohue, M; Omori, T; Sugimura, K; Takahashi, H; Tomokuni, A; Yanagimoto, Y; Yano, M; Yasui, M	1
Friberg, LE; Karlsson, MO; Netterberg, I; Nielsen, EI	1
Chen, L; Guo, R; Li, WF; Lin, AH; Liu, X; Ma, J; Mao, YP; Sun, Y; Tang, LL; Xu, C; Yang, SP; Zhang, Y; Zhou, GQ	1
Chen, S; Chen, Y; Hu, Y; Jiao, S; Li, J; Yan, X; Zhang, G; Zhang, Y	1
Bteich, J; Ernsting, MJ; Hoang, B; Kiyota, T; Li, SD; Tang, WS; Undzys, E	1
Blackwell, K; Gascon, P; Gattu, S; Harbeck, N; Krendyukov, A; Li, Y	1
Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T	1
Aviñó, V; Bayo, J; Jiménez, F; Toscano, F	1
Abe, T; Chijimatsu, H; Furuya, K; Hayashi, H; Kondo, J; Kubo, H; Maeda, Y; Nagano, H; Nagashima, Y; Somura, H; Takemoto, N; Yahara, N; Yamamoto, S	1
Baumann, A; Benhamida, S; Fiteni, F; Houédé, N; Lefebvre, L; Nadjafizadeh, S; Orillard, E; Paillard, MJ; Pivot, X; Roland, A; Selmani, Z; Vienot, A	1
Bouzguenda, R; Daoud, J; Fourati, N; Frikha, M; Ghorbel, A; Mnejja, W; Siala, W; Toumi, N	1
Chan, K; Chan, M; Chan, T; Lam, D; Law, K; Lee, EKC; Poon, DMC	1
Buttigliero, C; Di Maio, M; Di Stefano, RF; Guglielmini, P; Lacidogna, G; Leone, G; Numico, G; Pignataro, D; Scagliotti, GV; Tucci, M; Vignani, F; Zichi, C	1
Heishi, T; Ishida, H; Ito, K; Kamei, T; Konno-Kumagai, T; Maruyama, S; Okamoto, H; Onodera, Y; Sakurai, T; Sato, C; Taniyama, Y; Teshima, J	1
Kai, M; Kubo, M; Kurata, K; Mori, H; Nakamura, M; Yamada, M	1
Aujla, PK; Beckett, LA; Lara, PN; Li, Y; Pan, CX; Parikh, M; Robles, DA	1
Aoki, M; Komori, K; Sandou, M; Takagi, M; Uejima, E; Yoshida, Y	1
Chen, QY; Guo, L; Guo, SS; Li, XY; Liang, YJ; Lin, C; Lin, HX; Liu, LT; Liu, SL; Mai, HQ; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xie, HJ; Yan, JJ; Yang, ZC	1
Dohi, O; Doi, T; Fujiwara, H; Handa, O; Ishikawa, T; Itoh, Y; Kamada, K; Konishi, H; Naito, Y; Ohta, T; Okayama, T; Shiozaki, A; Takagi, T; Uchiyama, K; Yasuda, T; Yoshida, J; Yoshida, N	1
Aradi, I; Bondarenko, I; Grecea, D; Horvat-Karajz, K; Illes, A; Kahan, Z; Perjesi, L; Smakal, M; Tjulandin, S	1
Goodwin, A; O'Connell, DL; Wilcken, N; Willson, ML; Zaheed, M	1
Beijnen, JH; Bergman, AM; Crombag, MBS; de Vries Schultink, AHM; Huitema, ADR; Otten, HM; Schellens, JHM; van Werkhoven, E	1
Gemma, A; Goto, K; Ichinose, Y; Imamura, F; Inoue, A; Kiura, K; Maemondo, M; Morita, S; Nakagawa, K; Nishio, M; Nokihara, H; Ohe, Y; Okamoto, I; Saka, H; Sakai, H; Seto, T; Shingyoji, M; Sugawara, S; Takahashi, T; Takeda, K; Tamura, T; Yamamoto, N	1
Fukuda, S; Fukumitsu, K; Ito, Y; Kanemitsu, Y; Maeno, K; Niimi, A; Oguri, T; Ohkubo, H; Sone, K; Takakuwa, O; Takemura, M; Takeuchi, A; Uemura, T	1
Cheng, M; Qi, Y; Shi, J; Song, Z; Wang, M; Wang, X; Zhang, L	1
Furuya, Y	1
Beith, J; Boyle, FM; Chen, TYT; Currow, DC; Della-Fiorentina, SA; Johnston, A; Lin, E; Moylan, EJ; Tervonen, HE	1
Anagnostopoulos, A; Athanasiadis, A; Boukovinas, I; Georgoulias, V; Kachris, S; Lambrodimou, G; Makrantonakis, P; Polyzos, A; Saridaki, Z; Souglakos, J; Stoltidis, D	1
Andre, F; Chan, A; Chan, S; Gianni, L; Greil, R; Lichinitser, M; Lipatov, O; Mansutti, M; Mariani, P; Moore, N; Pallaud, C; Pivot, X; Prot, S; Romieu, GH; Semiglazov, V; Serrano, SV; Wardley, A	1
Koroleva, IA; Mochalova, AS	3
Ji, M; Li, J; Zhu, LN	1
Hong, DS; Im, YH; Kang, SY; Kim, HY; Kwon, HC; Lee, HJ; Lee, S; Park, IH; Park, JH; Park, KH; Park, S; Park, YH; Seo, JH; Shin, SH; Sohn, JH	1
Biagioni, C; Biganzoli, L; Cavaciocchi, D; Di Leo, A; Pestrin, M; Sanna, G; Turner, N; Zafarana, E	1
Gandara, DR; Groshen, S; Iqbal, S; Lenz, HJ; Newman, EM; Shibata, SI; Synold, TW	1
Ando, R; Etani, T; Hashimoto, Y; Kawai, N; Kohri, K; Naiki, T; Okada, A; Okamura, T; Tozawa, K; Yasui, T	1
Autio, KA; Carrasquillo, JA; Heller, G; Hong, C; Larson, SM; Morris, MJ; Pandit-Taskar, N; Rathkopf, DE; Scher, HI; Slovin, SF; Stephenson, RD	1
Atrash, F; Billan, S; Doweck, I; Haim, N; Kaidar-Person, O; Kuten, A; Ronen, O	1
Bias, P; Bondarenko, I; Buchner, A; Elsaesser, R; Gladkov, OA	1
Cataruozolo, PE; Cesari, R; Collier, M; Cortés, J; Curigliano, G; Elias, A; Goldhirsch, A; Huang, X; Kern, KA; Khosravan, R; Pivot, X	1
Brito, RA; Childs, BH; Karr, M; Kennah, A; Raez, LE; Santos, ES; Wade, J; Webb, RT	1
Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Malamos, N; Mavroudis, D; Papakotoulas, P; Politaki, E; Polyzos, A; Tryfonidis, K; Xenidis, N	1
Cho, YJ; Choi, JY; Hwang, YS; Jeong, YY; Kang, JH; Kim, HC; Kim, HG; Kim, MG; Kim, MJ; Kim, SH; Lee, GW; Lee, JD	1
Brighenti, M; Curti, A; Donati, G; Lazzarelli, S; Liguigli, W; Martinotti, M; Negri, F; Olivetti, L; Passalacqua, R; Poli, R; Rovatti, M; Tomasello, G	1
Ding, CM; He, ZY; Li, K; Li, WL; Liu, W; Mao, WD; Sun, T; Wang, HM; Wang, J; Yao, Q; Zhang, MJ; Zhang, Y; Zhou, XL	1
Arena, MG; Barba, M; Belli, F; Di Lauro, L; Fattoruso, SI; Giannarelli, D; Maugeri-Saccà, M; Paoletti, G; Pizzuti, L; Sergi, D; Tomao, S; Vici, P	1
Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A; Ueda, Y; Yoshita, H	1
Cho, EK; Kang, JH; Kim, YH; Lee, KH; Min, YJ; Park, JY; Song, HS	1
Buzaid, AC; Sartor, O; Schutz, FA	1
Ahn, H; Ahn, JH; Choi, MK; Hong, BS; Hong, JH; Hong, SW; Jeong, IG; Kim, Y; Lee, JL; Lee, KH; Song, C	1
Azuma, M; Hayakawa, K; Higuchi, K; Ishido, K; Ishiyama, H; Katada, C; Katada, N; Koizumi, W; Komori, S; Sasaki, T; Tanabe, S	1
Kwon, WA; Lee, JW; Oh, TH; Park, SC	1
Conte, M; Ellingrod, VL; King, AN; O'Malley, M; Ramnath, N	1
Daimon, T; Eto, T; Hatori, M; Hayashi, H; Ikeda, M; Inoue, K; Itoh, K; Kamezato, M; Taku, K; Tsuji, D	1
Hasegawa, S; Kikuchi, E; Kosaka, T; Miyajima, A; Mizuno, R; Morita, S; Nagata, H; Nakagawa, K; Oya, M; Shigeta, K; Shinoda, K; Yasumizu, Y; Yazawa, S	1
Bias, P; Buchner, A; Elsässer, R	1
Hamaguchi, T; Honma, Y; Iwasa, S; Kato, K; Nagashima, K; Nishikawa, A; Okita, N; Sasaki, Y; Sawada, R; Shimada, Y; Shirakawa, T; Shoji, H; Takahashi, N; Takashima, A; Yamada, Y	1
Guo, H; Liu, Y; Yang, S; Yao, S; Yao, Z; Zhao, Y	1
Chakravarty, A; Mettetal, JT; Palani, S; Patel, M; Shyu, WC; Yang, J	1
Agelaki, S; Boukovinas, I; Christophyllakis, Ch; Georgoulias, V; Kalbakis, K; Kalykaki, A; Kentepozidis, N; Kontopodis, E; Kotsakis, A; Mavroudis, D; Vamvakas, L; Vardakis, N	1
Fukuchi, M; Ieta, K; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Saito, K; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T	1
Ito, Y; Masuda, N; Nakamura, S; Shimazaki, R; Tamura, K; Tokuda, Y	1
Albert, DH; Belmont, LD; Boghaert, ER; Chen, J; Diaz, D; Elmore, SW; Fairbrother, WJ; Huang, DC; Jin, S; Kovar, P; La, N; Leverson, JD; Lowes, KN; Ma, XM; Magoc, TJ; Mitten, MJ; Nimmer, P; Oleksijew, A; Phillips, DC; Rosenberg, SH; Sampath, D; Smith, M; Souers, AJ; Tahir, SK; Tao, ZF; Tarrant, JM; Tse, C; Vaidya, KS; Wang, L; Wendt, MD; Xiao, Y; Xue, J; Zhang, H	1
Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y	1
Hayashi, T; Hirakawa, M; Hori, M; Kato, J; Kobune, M; Miyanishi, K; Nakata, K; Ohnuma, H; Okagawa, Y; Osuga, T; Sagawa, T; Sakata, K; Sato, T; Sato, Y; Someya, M; Takayama, T; Takimoto, R	1
Ando-Makihara, R; Hayashi, Y; Makino, Y; Motonaga, M; Ohe, Y; Takano, M; Yamamoto, N	1
Alvarez, E; Campos Balea, B; Casal, J; Castellanos, J; Fernández, A; Gallardo, E; González, P; Grande, C; Jorge, M; López, C; López, R; Quintero-Aldana, G; Salgado, M; Varela, S; Villanueva, MJ	1
Carducci, M; Chen, YH; Cooney, MM; DiPaola, RS; Dreicer, R; Eisenberger, M; Garcia, JA; Hahn, N; Hussain, M; Jarrard, DF; Kohli, M; Liu, G; Picus, J; Shevrin, D; Sweeney, CJ; Vogelzang, NJ; Wong, YN	1
de Bruijn, P; de Graan, AM; de Wit, R; Elbouazzaoui, S; Eskens, FA; Hamberg, P; Martens, JW; Mathijssen, RH; Nieuweboer, AJ; Smid, M; Sparreboom, A; van Schaik, RH	1
Hao, X; Li, C; Su, W; Zhang, J; Zhang, S	1
Iwasaki, K; Mitomo, K; Nakayama, S; Tamate, S; Uchiyama, K; Yamada, M	1
Balis, FM; Chen, CC; Cole, D; Fox, E; Pastakia, D; Widemann, BC; Yang, SX	1
Hara, F; Hozumi, Y; Imoto, S; Matsubara, N; Mukai, H; Nishimura, R; Ohashi, Y; Park, Y; Sagara, Y; Saito, T; Shimozuma, K; Takano, T; Takashima, T; Toyama, T; Tsurutani, J; Watanabe, T	1
Hayata, K; Iwahashi, M; Katsuda, M; Matsumura, S; Nakamori, M; Nakamura, M; Ojima, T; Yamaue, H	1
Cha, E; Green, M; Jin, J; Stroh, M; Wada, R; Zhang, N	1
Bi, J; Cao, B; Chen, L; Dai, H; Deng, Y; Hu, J; Jia, L; Jiang, H; Li, W; Meng, C; Nan, K; Shen, K; Shen, P; Shi, J; Song, Y; Sun, Q; Sun, Y; Tang, L; Tian, F; Tong, Z; Wang, S; Wu, G; Wu, Q; Wu, Y; Xie, X; Xu, B; Yu, J; Yuan, Z; Yue, S; Zhang, B; Zhang, Q; Zhang, Y; Zhuang, W	1
Arai, Y; Dmuchowski, C; Fakhoury, A; Infante, JR; Krivoshik, A; LoRusso, P; Luke, JJ; Schuster, R; Shapiro, GI; Yamazaki, T	1
de Bono, J; de Wit, R; Liewen, H; Meisel, A; Sartor, O; Stenner-Liewen, F; Vogt, DR; von Felten, S	1
Hayata, K; Iwahashi, M; Kato, T; Katsuda, M; Kitadani, J; Nakamori, M; Nakamura, M; Ojima, T; Tabata, H; Takeuchi, A; Yamaue, H	1
Hou, MF; Kim, SB; Nguyen Ba, D; Sayeed, A; Shah, MA; Shen, ZZ; Villalon, AH	1
Fukuchi, M; Inose, T; Kato, H; Kuwano, H; Masuda, N; Miyazaki, T; Nakajima, M; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N	1
Matsuhashi, N; Okumura, N; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K	1
Barber, J; Button, M; Catlow, C; Kumar, S; Mason, MD; Palaniappan, N; Smith, C; Staffurth, J; Tanguay, JS	1
Arai, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K	1
Bersanelli, M; Buti, S	1
Gondo, T; Hirasawa, Y; Horiguchi, Y; Nakagami, Y; Nakashima, J; Namiki, K; Ohno, Y; Ohori, M; Sugihara, T; Tachibana, M; Takizawa, I	1
Chen, CC; Chen, CY; Chen, WM; Chen, YY; Chou, WC; Lee, KD; Lu, CH; Wang, TY; Yang, LY	1
Fujiwara, K; Kigawa, J; Nagao, S; Nishimura, R; Shimada, M; Shoji, T; Sugiyama, T; Takeshima, N; Takizawa, K; Yamaguchi, S	1
Clarke, NW; James, ND; Parmar, MK; Ritchie, AW; Sydes, MR	1
Aogi, K; Dalal, R; Gao, L; Ibrahim, A; Iwata, H; Masuda, N; Sasaki, Y; Xu, Y; Yoshikawa, R	1
Acheson, AK; Agiro, A; Barron, JJ; Lyman, GH; Ma, Q; Malin, JL; Patt, DA; Rosenberg, A; Schilsky, RL; Wu, SJ	1
Altundag, K; Barnadas, A; Botha, M; Chan, A; Cinieri, S; Coskun, U; Dodyk, P; Lazzarelli, S; Rauch, D; Tubiana-Mathieu, N; Vandebroek, A; Villanova, G	1
Aftimos, P; Awada, A; Cesari, R; Curigliano, G; Dees, EC; Huang, B; Jiang, Y; Kern, KA; Locatelli, MA; LoRusso, PM; Pegram, MD; Shaik, MN	1
Chuman, H; Hatano, H; Hiraga, H; Hosaka, M; Iwamoto, Y; Joyama, S; Kaya, M; Kubo, T; Morioka, H; Nagano, A; Nishida, Y; Takahashi, M; Tanaka, K; Toguchida, J; Tsumura, H; Yoshikawa, H	1
Aizawa, T; Ishibashi, N; Maebayashi, T; Saito, T; Sakaguchi, M	1
Allali, J; Loulergue, P; Mir, O; Viard, JP	1
Onizawa, K; Otsuka, Y; Yamagata, K; Yoshida, H	1
Chan, J; Ip, EJ; Lee-Ma, A; Troxell, LS	1
Jiang, WQ; Lin, XB; Liu, DG; Teng, XY; Zhong, JT; Zhou, NN	1
Bolger, M; Dunphy, F; Edelman, MJ; Green, MR; Gu, L; Hoffman, P; Khatri, J; Miller, AA; Vokes, EE; Wang, XF	1
Bedikian, AY; Camacho, LH; Frost, AM; Hernandez, IM; Hwu, P; Hwu, WJ; Jack, MA; Kim, KB; Ng, C; Papadopoulos, NE	1
del Giglio, A; Eniu, A; Ganea-Motan, D; Lubenau, H; Topuzov, E	1
Calvo, L; Cruz, JJ; García-Mata, J; García-Palomo, A; Mel, R; Ramos, M	1
Gao, YJ; Guan, XQ; Li, EX; Liu, JW; Nan, KJ; Sheng, LJ; Song, SP; Sun, Y; Wang, DL; Wang, XW; Wang, ZP; Wang, ZX; Yu, XJ; Zhang, MH; Zhang, XR	2
Ding, G; Fu, Q; Ren, H; Su, FX; Wang, N; Wang, YJ; Wu, Q; Yang, JQ; Ye, ZB; Zhang, J; Zhou, LZ	1
Al-Batran, SE; Ehninger, G; Goekkurt, E; Hartmann, JT; Jaeger, E; Kramer, M; Mogck, U; Pauligk, C; Stoehlmacher, J	1
Barbolosi, D; Frances, N; Freyer, G; Iliadis, A; Meille, C	1
Kendrick, JE; Kilgore, LC; Matthews, KS; Numnum, TM; Shipman, KA; Straughn, JM; Whitworth, JM	1
Gennatas, K; Gennatas, S; Michalaki, V	1
Morgan, A; Sutton, A; Wailoo, A	1
Han, T; Hwang, SW; Jang, KM; Jung, JY; Kim, HJ; Kim, HS; Kim, HY; Kim, JH; Kim, MJ; Kwon, JH; Park, S; Song, HH; Yang, DH; Yoo, KS; Zang, DY	1
Aapro, MS; Ajani, J; Baker, J; Martin, M; Scotté, F; von Minckwitz, G; Winther, D	2
Barrett-Lee, P; Bartlett, JM; Bliss, JM; Bloomfield, D; Cameron, D; Canney, P; Coleman, R; Dowsett, M; Earl, H; Ellis, I; Ellis, P; Hall, E; Hopwood, P; Johnson, L; Johnston, S; O'Reilly, S; Peckitt, C; Poole, C; Smith, I; Twelves, C; Verrill, M; Wardley, A; Yarnold, J	1
Minami, H; Ozawa, K; Sato, H	4
Aramendía, JM; Arbea, L; Aristu, J; De la Cruz, S; Espinós, J; Fernández-Hidalgo, O; Martínez-Monge, R; Moreno, M; Nieto, Y; Pina, L; Regueira, FM; Santisteban, M; Sola, J; Zornoza, G	1
Addeo, R; Capasso, E; Caraglia, M; Cennamo, G; Del Prete, S; Faiola, V; Guarrasi, R; Montella, L	1
Furuta, I; Kurashina, K; Kurita, H; Miyata, M; Nozaki, S; Wada, S; Yamamoto, E	1
Hu, WH; Li, JS; Peng, M; Qi, SN; Xie, FY; Zou, GR	1
Abali, H; Budakoglu, B; Güler, T; Odabaşi, H; Oksüzoğlu, B; Ozdemir, NY; Uncu, D; Zengin, N	1
Haj, R; Higgins, B; Leung, MG; Myers, J; Myers, R; Rajagopal, S; Soong, D	1
Gemma, A; Hino, M; Kudoh, S; Nagao, K; Niitani, H; Tada, Y; Takiguchi, Y; Yoshimori, K; Yoshimura, A	1
Bae, SH; Baek, JH; Do, YR; Kim, JY; Kim, MK; Lee, KH; Park, KU; Ryoo, HM; Song, HS	1
Characiejus, D; Fokas, V; Juodzbaliene, E; Juozaityte, E; Kregzdyte, R; Liutkauskiene, S; Sveikata, A	1
Cho, SH; Cho, YJ; Go, SI; Hwang, YS; Jeong, YY; Kang, JH; Kim, HC; Kim, HG; Kim, SH; Lee, GW; Lee, JD	1
Bae, WK; Cho, SH; Chung, IJ; Chung, WK; Hwang, JE; Lee, JK; Lim, SC; Shim, HJ	1
Anami, S; Fujii, C; Kitada, N; Kondoh, M; Minegaki, T; Morita, S; Nishino, M; Takara, K; Watari, M; Yasuda, J	1
Abrial, C; Barthomeuf, C; Bayet-Robert, M; Chollet, P; Durando, X; Gachon, F; Kwiatkowski, F; Leheurteur, M; Mouret-Reynier, MA; Planchat, E	1
Ardavanis, A; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Kentepozidis, N; Kouroussis, C; Malamos, N; Mavroudis, D; Papakotoulas, P; Polyzos, A; Syrigos, K; Ziras, N	1
Borsellino, N; Carrozza, F; Caruso M, M; Cinieri, S; Colucci, G; Ferraù, F; Galetta, D; Gebbia, V; Leo, S; Lorusso, V; Mancarella, S; Mancuso, G; Palomba, G; Riccardi, F	1
Chang, H; Choi, HJ; Chung, HC; Kim, JH; Kim, SI; Kim, YT; Koo, JS; Moon, YW; Park, BW; Park, S; Roh, JK; Sohn, JH	1
Balser, S; Einmahl, S; Fuhr, U; Gascon, P; Kinzig-Schippers, M; Makhson, A; Muenzberg, M; Sörgel, F	1
Hirata, K; Kato, J; Kida, M; Kobune, M; Miyanishi, K; Niitsu, Y; Ohnuma, H; Ohta, H; Okubo, S; Sagawa, T; Sato, T; Sato, Y; Shintani, N; Takahashi, Y; Takayama, T; Takimoto, R; Tanaka, S; Yamaguchi, K	1
Fukushima, M; Ishiguro, H; Kanai, M; Kitano, T; Matsumoto, S; Mio, T; Misawa, A; Niimi, M; Nishimura, T; Sasaki, T; Tada, H; Teramukai, S; Yanagihara, K; Yasuda, H; Yoshimura, K	1
Dessard-Diana, B; Durdux, C; Langlois, A; Le Beller, C; Louet, AL; Loulergue, P; Mir, O; Viard, JP	1
Dyck, J; Huizing, MT; Rasschaert, M; Schrijvers, D; Specenier, P; Van den Brande, J; Vermorken, JB	1
Chen, QY; Guo, L; Huang, PY; Lin, HX; Wang, CT; Xu, M	1
Chen, QY; Guo, X; Hong, MH; Lu, X; Xiang, YQ; Zeng, Q	1
Bamias, A; Bobos, M; Christodoulou, Ch; Dimopoulos, MA; Fountzilas, G; Karina, M; Kostopoulos, I; Papakostas, P; Pectasides, D; Pentheroudakis, G; Samantas, E; Vourli, G	1
Corn, BW; Geva, R	1
Guo, JF; Nie, XY; Peng, J; Wang, B; Wu, F; Xing, H; Zhang, B; Zhu, GY	1
Chan, A; Coyuco, JC; Fu, WH; Ng, R; Shih, V; Tan, SH	1
Inaji, H; Ishitobi, M; Komoike, Y; Koyama, H; Motomura, K	1
Egashira, H; Fujiwara, J; Honda, M; Izumi, Y; Kato, T; Miura, A; Monma, K; Nemoto, T; Ryotokuji, T	1
Arkenau, HT; de Bono, JS; Demers, L; Fong, PC; Gualberto, A; Karavasilis, V; Leitzel, K; Lipton, A; Molife, LR; Olmos, D; Paccagnella, L; Postel-Vinay, S; Reid, AH; Shaw, HM; Spicer, J; Vidal, L; Yap, TA; Yin, D	1
Bochicchio, AM; Budillon, A; Caraglia, M; Catalano, A; Facchini, G; Ferrari, E; Gentilini, D; Iaffaioli, RV; Leopardo, D; Marra, L; Marra, M; Morabito, A; Nasti, G; Perrone, F; Piccirillo, MC; Striano, S; Tortoriello, A; Vitale, G	1
Andersen, M; Pfeiffer, P; Schønnemann, KR; Yilmaz, M	1
Baker, SD; Carducci, MA; Franke, RM; Rudek, MA; Sparreboom, A	1
Bodrogi, I; de Bono, JS; Gravis, G; Gupta, S; Hansen, S; Kocak, I; Machiels, JP; Mackenzie, MJ; Oudard, S; Ozguroglu, M; Roessner, M; Sartor, AO; Shen, L	1
El Bary, NM; El Halim Mohamed Abu Hamar, A; El Shebiney, M; Mansour, S; Maria, A; Sadaka, E	1
Agelaki, S; Georgoulias, V; Kalykaki, A; Kentepozidis, N; Kontopodis, E; Kotsakis, A; Mavroudis, D; Sfakiotaki, G; Stathopoulos, G; Vamvakas, L; Vardakis, N	1
Atsukawa, K; Honda, T; Hoshino, G; Imai, S; Imajyo, K; Kanai, T; Kumamoto, Y; Nagase, T; Nakagawa, M; Nonaka, T; Ogawa, Y; Sakaguchi, T; Shiba, T; Wada, O	1
Al Zaman, A; Fraser, J; Steele, N; Yule, A	1
Pal, SK; Sartor, O; Twardowski, P	1
Fan, Y; Huang, ZY; Luo, LH; Yu, HF	1
Chen, ZW; Gu, LP; Shen, SP	1
Burris, HA; de Bono, JS; Hubner, A; Miller, K; Morris, T; Nathan, F; Payne, H; Stephenson, J; Taboada, M; Trump, DL	1
Ashcroft, L; Blackhall, F; Burt, P; Califano, R; Chittalia, A; Faivre-Finn, C; Griffiths, R; Harris, M; Lee, L; Lorigan, P; Taylor, P; Thatcher, N	1
Chilimoniuk, M; Maksimowicz, T; Olszewska, E	1
Federico, K; Lloyd, GK; Mainwaring, P; Millward, M; Mita, A; Mita, M; Nawrocki, S; Reddinger, N; Spear, MA	1
Danno, K; Imaoka, S; Iwazawa, T; Kagara, N; Kanoh, T; Kimura, Y; Monden, T; Nakano, Y; Ohnishi, T; Taniguchi, H; Tono, T; Yano, H	1
Bair, AH; Bycott, P; Chan, S; Joy, AA; Kim, S; Liau, KF; Lluch, A; Rosbrook, B; Rugo, HS; Soulieres, D; Stopeck, AT; Verma, S	1
Fujisawa, K; Iwamoto, S; Miyamoto, Y; Nagai, H; Ohe, G; Takamaru, N; Tamatani, T; Uchida, D	1
Balzano, G; Belli, C; Cappio, S; Cereda, S; Doglioni, C; Fugazza, C; Ghidini, M; Longoni, S; Nicoletti, R; Passoni, P; Reni, M; Rezzonico, S; Rognone, A; Slim, N; Villa, E	1
Berrocal, A; Blasco, A; Blasco, S; Bremnes, RM; Caballero, C; Camps, C; Del Pozo, N; Iranzo, V; Jantus-Lewintre, E; Rosell, R; Sirera, R; Tarón, M	1
Androulakis, N; Boukovinas, I; Constantinides, CA; Georgoulias, V; Karampeazis, A; Kentepozidis, N; Kostakopoulos, A; Kotsakis, A; Markos, V; Mavroudis, D; Papakotoulas, P; Polyzos, A; Samonis, G; Vardakis, N; Ziras, N	1
Ae, T; Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Nakayama, N; Naruke, A; Nishimura, K; Sasaki, T; Takagi, S; Tanabe, S	1
Blackford, A; Chung, K; Cosgrove, D; De Jesus-Acosta, A; Diaz, LA; Donehower, RC; Flores, EI; Kinsman, K; Laheru, D; Le, DT; Oliver, GR; Wilfong, LS; Zheng, L	1
Amarantidis, K; Chamalidou, E; Chelis, L; Deftereos, S; Dimopoulos, P; Kakolyris, S; Karanikas, M; Karayiannakis, A; Michailidis, P; Tentes, A; Xenidis, N	1
Advani, PP; Kossoff, EB; Levine, EG; Ngamphaiboon, N; O'Connor, TL	1
Eckhoff, L; Knoop, A; Moeller, S; Nielsen, M	1
Boni, L; Caffo, O; de Marinis, F; Dondi, D; Ferraù, F; Galligioni, E; Gamucci, T; Gebbia, V; Grossi, F; Moscetti, L; Nardi, M; Riccardi, F	1
Daga, H; Hida, T; Horio, Y; Ishikawa, S; Kobayashi, K; Shimizu, J; Takeda, K; Tokunaga, S	1
Hatake, K; Hosonaga, M; Ito, Y; Iwase, T; Takahashi, S; Tokudome, N	1
Douillard, JY; Jiang, GL; Kim, ES; Li, LY; Liao, ML; Milenkova, T; Sun, Y; Wu, YL	1
Beckett, LA; Davies, AM; Gandara, DR; Hesketh, PJ; Lara, PN; Lau, D; Li, T; Mack, PC; Perkins, N; Sangha, R	1
Chan, CH; Chen, CC; Chen, PT; Chen, WC; Huang, CE; Kuan, FC; Lee, KD; Lu, CH; Wang, WH; Wu, JY	1
Booser, D; Brewster, A; Cristofanilli, M; Ensor, J; Giordano, SH; Gladish, G; Gonzalez-Angulo, AM; Hortobagyi, GN; Moore, J; Moulder, S; Murray, JL; Rivera, E; Tran, HT	1
Freeman, S; Jenkins, P; Scaife, J	1
Deuss, B; Dickgreber, N; Nagel, S; Pabst, S; Roscher, K; Salm, T; Schuette, W; Schumann, C; von Weikersthal, LF	1
Friberg, LE; Hansson, EK	1
Goto, N; Kayano, Y; Konno, A; Masada, M; Nakamura, T; Ohnaka, H; Tsukamoto, H; Watanabe, K; Yano, R	1
Characiejus, D; Juozaitytė, E; Liutkauskienė, S; Šeštakauskas, K; Sveikata, A; Tamošaitytė, L	1
Besova, NS	1
Rayson, D; Thompson, K; Younis, T	1
Assadourian, S; Falandry, C; Favier, L; Freyer, G; Fumoleau, P; Isambert, N; Soussan-Lazard, K; Trillet-Lenoir, V; You, B; Zanetta, S; Ziti-Ljajic, S	2
Ahn, JH; Ahn, SH; Jung, KH; Kim, KP; Kim, SB; Lee, JS; Yoon, DH	1
Barry, M; Bhatt, RS; Choueiri, TK; Febbo, P; Fennessy, FM; Galsky, MD; Hayes, J; Kantoff, PW; Oh, WK; Richie, JP; Ross, RW; Taplin, ME; Tempany, CM; Xie, W	1
Barron, R; Edelsberg, J; Kartashov, A; Lyman, G; Weycker, D	1
Fujii, H; Ishitani, K; Kamatani, N; Kanno, H; Matsui, H; Ohta, H; Saito, K; Uchiyama, T	1
Coulon Sfairi, MA; Dalenc, F; Delva, R; Espié, M; Hardy-Bessard, AC; Kockler, L; Lortholary, A; Monnier, A; Pavlyuk, M; Pierga, JY; Pivot, X; Serin, D; Veyret, C	1
Bozionelou, V; Georgoulias, V; Kalykaki, A; Karachaliou, N; Kontopodis, E; Mavroudis, D; Papadimitraki, E; Syrigos, K; Tryfonidis, K; Ziras, N	1
Abe, H; Cho, H; Kawai, Y; Kubota, Y; Mori, T; Tani, T; Umeda, T	1
Bian, L; Cao, Y; Huang, H; Jiang, Z; Song, S; Wang, T; Wu, S; Zhang, S	1
Agur, Z; Amir, O; Ariad, S; Ben-Av, R; Chan, S; Inbar, O; Kleiman, M; Mermershtain, W; Mukherjee, A; Vainas, O; Vainstein, V	1
Berardi, R; Bleuse, JP; Cappuzzo, F; de Wit, R; Dogliotti, L; Jannuzzo, MG; Mariani, M; Meulenbeld, HJ; Petroccione, A; Raymond, E; Santoro, A; Sternberg, CN; Tagawa, ST; Vinci, EM; Vitali, G	1
Akyol, M; Bayoglu, IV; Can, A; Demir, L; Dirican, A; Erten, C; Kucukzeybek, Y; Medeni, M; Somali, I; Tarhan, MO	1
Fan, Y; Li, Q; Ma, F; Wang, JY; Wang, WM; Xu, BH; Yuan, P; Zhang, P	1
Berry, WR; Galsky, MD; Leopold, L; Pond, GR; Sonpavde, G; Wood, BA	1
Albers, P; Arsov, C; Bokemeyer, C; Ecstein-Fraisse, E; Gschwend, J; Heidenreich, A; Heinrich, E; Honecker, F; Keck, B; Miller, K; Müller, SC; Otremba, B; Pfister, D; Retz, M; Rogenhofer, S; Scholz, HJ; Steiner, U; Trojan, L; Volkmer, B; Wirth, M	1
Hayashi, N; Kawahara, T; Kubota, Y; Misaki, H; Miyoshi, Y; Noguchi, K; Sano, F; Sekiguchi, Z; Teranishi, J; Uemura, H	1
Bustam, AZ; Ng, CH; Phua, CE; Saad, M; Taib, NA; Teh, YC; Yip, CH; Yusof, MM	1
Akiyama, H; Endo, I; Fujii, S; Hasegawa, S; Izumisawa, Y; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Ono, HA; Oshima, T; Takagawa, R; Tokuhisa, M	1
Bies, RR; Egorin, MJ; Jiang, C; Kroetz, DL; Lewis, LD; Markova, S; McLeod, HL; Miller, AA; Owzar, K; Ratain, MJ	1
Chen, MY; Chen, Z; Luo, JC; Wei, L; Wu, S	1
Ahn, MH; Han, SW; Jang, YH; Kim, HM; Kim, SY; Kim, Z; Lee, EJ; Lee, J; Lee, MH; Lim, C; Park, JH; Rho, J	1
Brassard, M; Budman, DR; Cohen, G; Dhami, M; George, T; Glaspy, J; Hackett, J; Holmes, FA; Jones, SE; Liang, BC; Meza, L; O'Shaughnessy, J; Richards, D; Savin, M; Vukelja, S; Yang, BB	1
Fife, K; Ganjoo, KN; Gordon, MS; Loehrer, PJ; Poirier, S; Sandler, AB; Seshadri, R; Warner, RE	1
Tsukuda, M	1
Degendorfer, P; Furlan, M; McCarthy, JS; Panzarella, T; Siu, LL; Tannock, IF	1
Bang, YJ; Boudraa, Y; Daglish, B; Heo, DS; Jacques, C; Kang, WK; Kang, YK; Kim, HC; Kim, NK; Kim, WS; Zuber, E	1
Borsellino, N; Cazzato, C; Colucci, G; Durini, E; Galetta, D; Gebbia, V; Giotta, F; Pezzella, G; Romito, S	1
Campos, B; Carrete, N; Constenla, M; Garcia-Arroyo, R; Lorenzo, I; Palacios, P	1
Chang, JY; Chen, LT; Chung, TR; Jan, CM; Liu, JM; Liu, TW; Shiah, HS; Whang-Peng, J; Wu, CW	1
Fukuoka, M; Inoue, A; Kunitoh, H; Mori, K; Nukiwa, T; Saijo, N	1
Cantin, J; Chang, J; Guevin, R; Lindsay, MA; Mackey, J; Nabholtz, JM; Patel, R; Reese, D; Riva, A; Tkaczuk, K; Vodvarka, P	1
Assadourian, S; Bonneterre, J; Fargeot, P; Guastalla, JP; Monnier, A; Namer, M; Roché, H	1
Balañá, C; Font, A; Guillot, M; Manzano, JL; Margelí, M; Richardet, M; Rosell, R; Sánchez, JJ; Sánchez, JM	1
Douillard, JY; Eckardt, J; Scagliotti, GV	1
Crawford, J	1
Baselga, J; Clemens, MR; Galid, A; Gascon, P; Green, MD; Guillem, V; Koelbl, H; Lalisang, RI; Liang, BC; Piccart, MJ; Renwick, J; Samonigg, H; Siena, S; Zani, V	1
Fujimura, M; Iwasa, K; Kasahara, K; Kimura, H; Myo, S; Nakao, S; Nishi, K; Shibata, K; Shintani, H; Shirasaki, H; Yasuda, U	1
Azli, N; Boudraa, Y; Cocquyt, V; Georgoulias, V; Hausmaninger, H; Paridaens, R; Ramazeilles, C; Samonnig, H; Van Aelst, F; Wildiers, J; Willemse, P; Zielinski, C	1
Bishop, JF; Boyer, MJ; Clarke, S; Goh, BC; Lehnert, M; McNeil, E; Millward, MJ; Rischin, D; Wong, J	1
Ando, M; Katsumata, N; Mukai, H; Watanabe, T	1
Markman, M	1
Brockstein, BE; Mani, S; Masters, GA; Ratain, MJ	1
Almanza, C; Amenedo, M; Gamazo, JL; Gómez-Martín, C; González-Ageitos, A; González-Quintas, A; Losada, G; Ramos, M; Romero, C; Togores, P	1
Airoldi, M; Bumma, C; Cattel, L; Marchionatti, S; Pedani, F; Recalenda, V; Tagini, V	1
Aravantinos, G; Bafaloukos, D; Christodoulou, C; Dimopoulos, MA; Fountzilas, G; Gogas, H; Kalofonos, HP; Kosmidis, P; Papadimitriou, C; Pavlidis, N	1
Corral, N; Esteban, E; Estrada, E; Fernández, Y; Fra, J; González de Sande, L; Lacave, AJ; Modollel, A; Muñiz, I; Palacio, I; Sala, M; Vieitez, JM	1
Busby, E; Carey, DE; Marques, MB; Reynolds, RE; Robert, F	1
Allen, HJ; Baker, C; Bosserman, LD; Chapman, Y; Figlin, RA; Gitlitz, BJ; Patel, R; Sanchez, JD; Shapiro, RM	1
Chun, JH; Han, JY; Hong, EK; Kim, HY; Lee, DH; Lee, HG; Lee, JS; Lee, SY; Shin, EH; Yoon, SM	1
Spiridonidis, CH	1
Green, MD; Hackett, JR; Holmes, FA; Meza, LA; Neumann, TA	1
Asano, K; Fukunaga, K; Hasegawa, N; Nakamura, H; Oyamada, Y; Watanabe, H; Yamaguchi, K	1
Aravantinos, G; Bafaloukos, D; Bamias, A; Bamias, C; Deliveliotis, C; Dimopoulos, MA; Gika, D; Kalofonos, C; Kosmidis, P; Kourousis, C; Koutras, A; Mitropoulos, D; Papadimitriou, C; Papakostas, P; Pectasides, D; Samantas, E; Xiros, N; Zervas, A	1
Brechot, JM; Breton, JL; Clouet, P; Debieuvre, D; Depierre, A; Ducolone, A; Lebeau, B; Lemarie, E; Milleron, B; Moro-Sibilot, D; Pujol, JL; Quoix, E; Vaylet, F; Vergnenegre, A; Zalcman, G	1
Ariyoshi, Y; Fukuoka, M; Hoso, T; Katakami, N; Kawahara, M; Kudoh, S; Matsui, K; Nakagawa, K; Nakano, T; Negoro, SI; Saito, H; Senba, H; Sugiura, T; Takada, Y; Yamamoto, N	1
Hamakawa, H; Hino, S; Nakashiro, KI; Shintani, S; Terakado, N	1
Hsu, Y; Sood, AK; Sorosky, JI	1
Belinson, J; Kulp, B; Markman, J; Markman, M; Peterson, G; Webster, K; Zanotti, K	1
Appia, F; Basser, R; Cebon, J; Chipman, M; Davis, ID; Green, M; Grigg, A; Mansfield, R; Mitchell, PL	1
Choi, SJ; Kim, HT; Park, YH; Ryoo, BY	1
Akaza, H; Hattori, K; Hinotsu, S; Kawai, K; Kojima, T; Miyanaga, N; Onozawa, M; Shimazui, T; Tsukamoto, S	1
Bunn, PA; De Marinis, F; Desch, C; Einhorn, L; Fossella, FV; Gatzemeier, U; Gervais, R; Hanna, N; Lim, HL; Manegold, C; Muller, T; Paoletti, P; Paul, S; Pereira, JR; Pless, M; Shepherd, FA; Szondy, K; Tsao, TC; von Pawel, J	1
Fujimoto, K; Hayasaka, M; Hirai, K; Koizumi, T; Koyama, S; Kubo, K; Takabayashi, Y; Tsunoda, T	1
Fujiwara, K; Gemba, K; Hiraki, S; Kishino, D; Kiura, K; Kozuki, T; Segawa, Y; Seki, N; Shinkai, T; Tabata, M; Takigawa, N; Tanimoto, M; Tokuda, Y; Ueoka, H; Watanabe, Y	1
Biason, R; Carnuccio, R; D'Amanzo, P; Fasan, S; Fila, G; Gatti, C; Ghi, MG; Mastromauro, C; Medici, M; Mione, CA; Nascimben, O; Oniga, F; Paccagnella, A; Pallini, A; Paro, S; Rossi, F; Turcato, G	1
Bradley, C; Crawford, SM; Dent, J; Dodwell, D; Humphreys, AC; Joffe, JK; Perren, TJ; Rodwell, S	1
Boku, N; Chin, K; Fujita, H; Hamaguchi, T; Hyodo, I; Muro, K; Ohtsu, A; Ohtsu, T; Takiyama, W	1
Blomqvist, C; Joensuu, H; Klaar, S; Madsen, EL; Nittby, LT; Poikonen, P; Sigurdsson, H; Sjöström, J	1
Im, YH; Jung, CW; Kang, WK; Kim, HY; Kim, JH; Kim, K; Lee, MH; Lee, SH; Lee, SI; Park, J; Park, JO; Park, K; Park, YS	1
Gemba, K; Harita, S; Kamei, H; Kiura, K; Nogami, N; Segawa, Y; Tabata, M; Tanimoto, M; Ueoka, H; Yonei, T	1
Ayers, D; Chi, KN; Chia, S; Cripps, C; Fry, D; Gelmon, KA; Huan, S; Janke, S; McIntosh, L; Seymour, LK; Shabbits, JA; Stewart, D; Walsh, W	1
Misawa, A; Misawa, H; Saitou, M; Ueta, K; Yasuda, M	1
Adrover, E; Alba, E; Amenedo, M; Balil, A; Barnadas, A; Casado, A; Fernández-Aramburo, A; Jara, C; Martín, M; Ramos, M; Sánchez-Rovira, P	1
Agelidou, A; Ardavanis, A; Boukovinas, I; Georgoulias, V; Kouroussis, C; Palamidas, P; Polyzos, A; Stavrinidis, E; Syrigos, K; Toubis, M; Tselepatiotis, E; Veslemes, M; Vlachonikolis, I	1
Goto, K; Hanada, K; Kakinuma, R; Kubota, K; Minami, H; Niho, S; Nishiwaki, Y; Nokihara, H; Ogata, H; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I	1
Albanell, J; Antón, A; Barnadas, A; Baselga, J; Climent, MA; Estaun, N; Garcia-Conde, J; Guillem, V; Laurent, C; Lluch, A; Losa, I; Mayordomo, JI; Tabernero, J; Tisaire, JL; Vermorken, JB	1
Furugen, Y; Hata, A; Hata, N; Hata, Y; Kurokawa, A; Mitsuhashi, N; Nishihara, S; Sone, Y	1
Hainsworth, JD	1
Berman, A; Chow, CK; Danforth, D; Eng-Wong, J; Lebowitz, PF; Liu, E; Merino, MJ; Swain, SM; Venzon, D; Zia, F; Zujewski, J	1
Atkinson, R; Coleman, R; Gabra, H; Gordon, A; Hay, A; Jayson, GC; Kaye, SB; Parkin, D; Paul, J; Vasey, PA	1
Eguchi, K; Inoue, F; Nakamura, H; Semba, H; Seto, T; Takeda, K; Takezako, Y	1
Aboulafia, DM; Jacobs, AD; Otero, H; Picozzi, VJ	1
Doliny, P; Gomez-Fernandez, C; Hurley, J; Lee, YJ; Powell, J; Reis, I	1
Anderson, CM; Barrett, B; Dorr, VJ; Lyss, AP; Malhotra, V; Perry, MC; Reynolds, M; Westgate, S	1
Caillaud, D; Clary, C; Clouet, P; Coudert, B; Couteau, C; D'Arlhac, M; Dabouis, G; Douillard, JY; Gervais, R; Le Groumellec, A; Maury, B; Monnier, A; Mornet, M; Rivière, A; Spaeth, D	1
Braun, D; Breton, JL; Clouet, P; Debieuvre, D; Ducolone, A; Gervais, R; Lebeau, B; Pujol, JL; Quoix, E; Tredaniel, J; Vaylet, F	1
Arizcun, A; Cruz, JJ; Fonseca, E; Gómez-Bernal, A; Martín, G; Martín, T; Olaverri, A; Rodríguez, CA; Sánchez, P	1
Baker, SD; Figg, WD; Graveland, W; Li, J; Sparreboom, A; ten Tije, AJ; Verweij, J	1
Amadori, D; Colantonio, I; Frassineti, GL; Ibrahim, T; Monti, M; Tesei, A; Zoli, W	1
Georgoulias, V; Panopoulos, C; Polyzos, A; Potamianou, A; Stergiou, J; Syrigos, K; Vamvakas, L	1
Antoniou, N; Bamias, A; Bozas, G; Deliveliotis, C; Dimopoulos, MA; Efstathiou, E; Kastritis, E; Kostakopoulos, A; Papadimitriou, C; Skarlos, D	1
Domchek, SM; Fox, K; Hwang, WT; Schwartz, J	1
Bamias, A; Bozas, G; Dimopoulos, MA; Efstathiou, E; Gika, D; Hamilos, G; Kakoyiannis, C; Kastritis, E; Moulopoulos, LA; Papadimitriou, C; Zorzou, MP	1
Baker, SD; Carducci, MA; Dawkins, F; Graveland, W; Pronk, T; Rogers, T; ten Tije, AJ; Verbruggen, MP; Verweij, J	1
Barajas-Figueroa, LJ; Carroll, RR; Neumann, TA; Schwartzberg, LS; Tjulandin, SA; Vogel, CL; Wiens, BL; Wojtukiewicz, MZ	1
Abenhardt, W; Brudler, O; Deutsch, G; Dorn, B; Heinemann, V; Jackisch, C; Kentenich, C; Leinung, S; Mair, W; Malekmohammadi, M; Papke, J; Stamp, J; Stauch, M; Stemmler, J; Vehling-Kaiser, U	1
Blohmer, JU; Caputo, A; Costa, SD; du Bois, A; Eidtmann, H; Gerber, B; Hilfrich, J; Jackisch, C; Kaufmann, M; Lampe, D; Merkle, E; Raab, G; Schütte, M; von Minckwitz, G	1
Kosmas, Ch; Malamos, NA; Pergantas, N; Rigatos, SK; Stathopoulos, GP; Stathopoulos, JG; Tsavdaridis, D; Xynotroulas, J	1
Cruz Hernández, JJ; Gómez Bernal, A; Martín González, I; Ocaña Fernández, A	1
Antón, A; Chan, S; Cognetti, F; Conte, P; Extra, JM; Green, M; Grimes, D; Kennedy, J; Lluch, A; Maraninchi, D; Marty, M; Mauriac, L; Mayne, K; O'Byrne, K; Snyder, R; Tubiana-Hulin, M; Ward, C	1
Au, GK; Chua, DT; Sham, JS	1
Agelidou, A; Androulakis, N; Boukovinas, I; Chandrinos, V; Georgoulias, V; Ignatiadis, M; Kentepozidis, N; Mylonaki, E; Vossos, A; Zachariadis, E; Ziotopoulos, P	1
Bang, YJ; Ham, HS; Hong, YS; Im, SA; Im, YH; Kim, KW; Kim, SB; Kim, TY; Kim, WK; Lee, J; Lee, KE; Lee, KH; Lee, MA; Lee, MH; Lee, NS; Lee, SN; Park, HS; Park, YH; Seo, JH; Song, HS	1
Horai, T; Matsuda, M; Morikawa, A; Nakagawa, K; Nishio, M; Ohyanagi, F; Okumura, S; Sato, Y; Tabata, D	1
Akerman, P; Barnett, JM; Berkenblit, A; Harrington, D; Iannitti, D; Maia, C; Miner, T; Nadeem, A; Rathore, R; Roye, D; Safran, H; Stuart, K; Tsai, JY	1
Ando, S; Iida, T; Kimura, H; Nakajima, T; Suzuki, M	1
Ahn, JH; Kang, YK; Kim, SB; Kun Kim, W; Lee, JS; Sohn, HJ	1
Creaven, PJ; Fakih, MG; French, RA; Javle, M; Ramnath, N; Repinski, TV; Schwarz, JK; Strychor, S; Trump, D; Zamboni, BA; Zamboni, WC	1
Ahluwalia, MS; Daw, HA	1
Noronha, V	1
Estepa-Alonso, MJ; Liso-Rubio, FJ; Luis-Fernández, J; Rangel-Mayoral, JF	1
Hahn, M; Lauschner, I; Rudlowski, C; Schneeweiss, A; Schuetz, F; Sinn, HP; Sohn, C; von Fournier, D	1
Kuramoto, K; Terao, I	1
Bunn, P; Kelly, K; Magree, L; Rabinovitch, R; Sunpaweravong, P	1
Fukuda, M; Hatakeyama, S; Kashiwagi, R; Miyamoto, Y; Miyoshi, K; Murayama, D; Musashi, T; Nagai, H; Nanjo, H; Ohnuki, T; Yamaoka, K	1
Crown, J; Mackey, J; Martin, M; Vogel, C	1
Fukuda, T; Hosoi, H; Okamoto, H; Yamanaka, T; Yane, K	1
Bang, SJ; Cho, HR; Kim, DH; Kim, GY; Kim, H; Min, YJ; Park, JH	1
Kohno, N	1
Fumoleau, P; Levy, C	1
Antón, A; Arcusa, A; Bayo, JL; Calvo, L; Carrasco, E; Florián, J; Martín-Richard, M; Mayordomo, JI; Pelegrí, A; Vásquez, S; Virizuela, J	1
Hamada, K; Kubota, K; Mori, S; Nakagawa, A; Suzuki, N; Tagaya, N	1
André, T; Bennamoun, M; Carola, E; Flesch, M; Gamelin, E; Louvet, C; Nguyen, S; Rebischung, C; Van Ongeval, J; Ychou, M	1
Bay, JO; Blay, JY; Brain, E; Bui, NB; Cherix, S; Chevreau, C; Cioffi, A; Coindre, JM; Emile, G; Fayette, J; Isambert, N; Kwiatkowski, F; Le Cesne, A; Leyvraz, S; Penel, N; Peyrade, F; Piperno-Neumann, S; Ray-Coquard, I	1
Ford, HE; Hall, M; Harries, M; Johnston, SR; Makris, A; Miles, DW; Miller, L; Smith, IE; Yap, YS	1
Fujii, H; Igarashi, T; Itoh, K; Kawada, K; Minami, H; Saeki, T; Sasaki, Y; Tahara, M	1
Cirillo, I; de Bruijn, P; de Jonge, MJ; Felici, A; Loos, WJ; Mathijssen, RH; Nooter, K; Verweij, J	1
Arimoto, T; Hara, H; Harada, H; Hosogi, S; Iwasaki, Y; Kohno, K; Marunaka, Y; Nakanishi, M; Natsuhara, A; Nishimura, T; Ohsugi, S; Takesako, T; Tsubokura, T; Ueda, M; Yamada, T	1
Alberti, D; Arzoomanian, R; Binger, K; Dubey, S; Feierabend, C; Hutson, P; Schiller, JH; Volkman, J; Wilding, G	1
Desai, K; Einstein, M; Fields, A; Goel, S; Goldberg, G; Macapinlac, M; Mani, S; Martin, R; Volterra, F; Wadler, S; Wong, B	1
Ahn, JS; Im, YH; Kang, JH; Kang, WK; Lee, J; Lee, SI; Lim, HY; Park, JO; Park, K; Park, KW; Park, YS	1
Adrover, E; Antón, A; Arcusa, A; Calvo, L; del Prado, PM; Fernandez-Chacón, C; Grosse, R; Iglesias, L; Isla, D; Lluch, A; López-Vega, JM; Martín, M; Mel, JR; Muñoz, M; Ramos, M; Rodríguez-Lescure, A; Roset, M; Ruiz, A; Seguí, MA; Zaluski, J	1
Crom, D; Moore, K	1
Arun, BK; Eder, JP; Eiseman, IA; Garland, LL; Hidalgo, M; Lenehan, PF; Lovalvo, JL; Mendelson, DS; Olson, SC; Ryan, DP	1
Chen, Q; Chen, ZY; Chu, DT; Han, FC; Li, JL; Li, LY; Lin, YC; Liu, JW; Nan, KJ; Song, SP; Wang, YD; Zhang, XR; Zheng, YH; Zhu, YZ	1
Hihara, J; Tanabe, K; Ukon, K; Wada, Y; Yoshida, K	1
Egashira, A; Kakeji, Y; Maehara, Y; Morita, M; Oki, E; Takahashi, I	1
Bauernhofer, T; Dandachi, N; Holub, R; Samonigg, H; Schippinger, W	1
Bria, E; Ciccarese, M; Cognetti, F; Cuppone, F; Facciolo, F; Giannarelli, D; Izzo, F; Milella, M; Nisticò, C; Terzoli, E	1
Ando, M; Katsumata, N; Mizuno, T; Mukai, H; Shimizu, C; Watanabe, T	1
Chatelut, E; Henningsson, A; Karlsson, MO; Kloft, C; Wallin, J	1
Beinert, T; Binder, D; Grah, C; Schäper, C; Schweisfurth, H; Siebert, G; Suttorp, N; Temmesfeld-Wollbrück, B	1
Akamatsu, H; Imazu, Y; Koshida, Y; Motegi, K; Murayama, T; Ohyama, R; Toeda, H; Toriumi, F; Yoneyama, K	1
Alexandre, J; Dieras, V; Girre, V; Goldwasser, F; Grabar, S; Hérait, P; Jullien, V; Montheil, V; Pons, G; Rabillon, F; Rey, E; Tran, A; Treluyer, JM	1
Fortner, BV; Houts, AC; Schwartzberg, LS	1
Anthony, SP; Asmar, L; Blum, JL; Boehm, KA; Bordelon, JH; Holmes, FA; Hyman, WJ; Jones, SE; Khandelwal, P; Kirby, R; McIntyre, KJ; Mennel, RG; Meyer, WG; Negron, AG; O'Shaughnessy, JA; Pippen, JE; Richards, DA; Sandbach, J; Savin, MA; Vukelja, S	1
Eguchi, K; Hada, E; Izumi, Y; Kawamura, M; Kobayashi, K; Koike, T; Sakaguchi, H; Yamato, Y	1
Wang, JY; Xu, BH; Yuan, P; Zhao, LM	1
Abdel-Khalek, Z; Bitar, N; Charafeddine, M; Chehal, A; Dandashi, A; Dheiny, M; El-Saghir, NS; Jalloul, R; Khalifeh, MJ; Otrock, ZK; Shamseddine, AI; Wehbeh, M; Yassine, HR	1
Iwabuchi, H; Nakayama, S; Uchiyama, K	1
Adachi, M; Ando, K; Hirose, T; Hosaka, T; Ishida, H; Kusumoto, S; Nakashima, M; Ohmori, T; Shirai, T; Sugiyama, T	1
Azuma, K; Hashine, K; Miura, N; Numata, K; Sumiyoshi, Y	1
Akehi, S; Gangi, J; Honda, K; Kurokawa, T; Masuda, J; Nomoto, M; Okada, K; Sagawa, T; Soga, H; Tashiro, H; Watanabe, R; Watanabe, Y; Yasuoka, Y	1
Honda, J; Kai, N; Kikuchi, K; Kikukawa, H; Kuwahara, T; Matsumoto, K; Nakanishi, J; Takahashi, W; Ueda, S; Wada, Y	1
Beaumont, J; Boros, L; Chidiac, T; Dowlati, A; Du, H; Graham, P; Lilenbaum, R; Rubin, M; Samuel, J; Seigel, L	1
Yoneda, S	1
Li, QY; Ma, SL; Yu, XM; Zhu, LM	1
Cescon, TP; Dennison, SK; Geyer, CE; Jacobs, SA; Raymond, JM; Seeger, J; Swain, SM; Wilson, JW; Wolmark, N	1
Arena, MG; Di Lauro, L; Foggi, P; Lopez, M; Nunziata, C; Sperduti, I	1
Adamson, PC; Franklin, JL; Fu, C; Krailo, M; Reaman, G; Seibel, NL	1
Abe, M; Hamada, H; Higaki, J; Irifune, K; Ito, R; Kadowaki, T; Katayama, H; Nishimura, K; Sakai, K; Shiode, M	1
Guan, JH; Huan, HY; Mao, F; Sun, Q; Zhou, YD	1
Buesa, JM; Capelan, M; Esteban, E; Estrada, E; Fernández, Y; Fra, J; Jiménez, P; Jiménez-Lacave, A; Llorente, B; Luque, M; Muñiz, I; Vieitez, JM; Villanueva, N	1
Abe, M; Dehari, H; Hiratsuka, H; Kido, Y; Kobayashi, J; Miyazaki, A; Nagai, I; Nakamori, K; Takemura, K; Tomihara, K; Yamamoto, T	1
Agostana, B; Aitini, E; Ardizzoia, A; Ardizzoni, A; Bajetta, E; Bochicchio, AM; Bordonaro, R; Botta, M; Buzzoni, R; Cicero, G; Comella, G; Di Bartolomeo, M; Duro, M; Fagnani, D; Ferrario, E; Gevorgyan, A; Katia, D; Kildani, B; Mantovani, G; Mariani, L; Marini, G; Massidda, B; Mozzana, R; Oliani, C; Palazzo, S; Pinotti, G; Reguzzoni, G; Schieppati, G; Villa, E; Zilembo, N	1
Fan, L; Goh, BC; Guo, JY; Hor, SY; Lee, HS; Lee, SC; Lim, RC; Lim, YW; Tan, T; Wang, LZ; Wong, CI	1
Asmar, L; Boehm, KA; McCollum, D; Richards, D; Sborov, M; Wilfong, L; Zhan, F	1
Goh, BC; Lee, HS; Lee, SC; Soo, R; Sukri, N; Tham, LS; Wang, LZ; Wong, CI; Yong, WP	1
Lambert-Falls, R; Modugno, S	1
Debled, M; Donamaria, C; Durand, M; Floquet, A; Houédé, N; Madranges, N; Mauriac, L	1
Chang, J; Cho, BC; Choi, HJ; Chung, KY; Kim, DJ; Kim, JH; Kim, SH; Kim, SK; Park, MS; Shin, SJ; Sohn, JH	1
Marino, P	1
Kiyotani, K; Kubo, M; Mushiroda, T; Nakamura, Y; Sugiyama, Y; Zembutsu, H	1
Fukushima, M; Garbo, CL; Ishiguro, H; Kitano, T; Toi, M; Ueno, T; Yanagihara, K; Yasuda, H; Yoshibayashi, H	1
Carcereny, E; Casado, E; Fernández-Llamazares, J; Font, A; Gallego, R; Guix, M; Manzano, JL; Maurel, J; Ramirez, JL; Rosell, R; Salazar, R; Tabernero, J; Taron, M	1
Akaza, H; Harabayashi, T; Hoshi, S; Koga, H; Naito, S; Sumiyoshi, Y; Tsukamoto, T	1
Ba-Ssalamah, A; Brodowicz, T; Hejna, M; Pluschnig, U; Püspök, A; Raderer, M; Schmidinger, M; Zacherl, J; Zielinski, CC	1
Albanell, J; Awada, A; Baselga, J; Canney, PA; Cardoso, F; Dirix, LY; Gascon, P; Gil, T; Piccart, MJ	1
Agelaki, S; Agelidou, A; Agelidou, M; Georgoulias, V; Geroyianni, A; Hatzidaki, D; Kakolyris, S; Kalykaki, A; Kotsakis, A; Mavroudis, D; Pallis, AG; Papakotoulas, P; Vardakis, N	1
Fumoleau, P; Lemevel, B; Maugard-Louboutin, C; Perrocheau, G	1
Francis, PA; Grant, SC; Heelan, RT; Kris, MG; Miller, VA; Pisters, KM; Rigas, JR; Venkatraman, ES; Woolley, K	1
Benner, S; Calayag, M; Fossella, FV; Glisson, B; Huber, M; Lee, JS; Lippman, S; Murphy, WK; Perez-Soler, R; Shin, DM	1
Foa, R; Norton, L; Seidman, AD	1
Ariyoshi, Y; Fukuoka, M; Furue, H; Furuse, K; Hasegawa, K; Ishitani, K; Kanamaru, R; Niitani, H; Noda, K; Taguchi, T	1
Alakl, M; Clavel, M; Franklin, H; Piccart, M; Prove, AM; Steward, W; ten Bokkel Huinink, WW; Tursz, T; Verweij, J; Wanders, J	1
Catimel, G; Clavel, M; Franklin, H; Hanauske, A; Kaye, SB; Le Bail, N; Mattijssen, V; Piccart, M; Verweij, J; Wanders, J	1
Taguchi, T	1
Hirabayashi, K; Kono, I; Noda, K; Ogita, Y; Taguchi, T; Terajima, Y; Yakushiji, M	1
Balmaceda, C; Barakat, R; Francis, P; Hakes, T; Hann, L; Phillips, M; Schneider, J	1
Adachi, I; Aoyama, H; Horikoshi, N; Narabayashi, M; Taguchi, T; Takashima, S; Watanabe, T	1
Trudeau, ME	2
Armand, JP; Couteau, C; Goncalves, E; Terret, C; Yakendji, K	1
Coatsworth, S; Einzig, AI; Recio, A; Rodriquez, R; Schuchter, LM; Wiernik, PH	1
Davison, JD; Francis, PA; Ganju, V; Michael, M; Millward, MJ; Rischin, D; Shapiro, JD; Toner, GC	1
Adamson, PC; Balis, FM; Berg, SL; Blaney, SM; Krailo, MD; Mosher, R; O'Brien, M; Poplack, DG; Reaman, GH; Seibel, NL	1
Diéras, V	2
Valero, V	3
Delorme, F; Janowska, A; Mackey, J; Nabholtz, JM; Noel, D; Paterson, A; Riva, A; Smylie, M	1
Azli, N; Delecroix, V; Féty, R; Fumoleau, P; Perrocheau, G	1
Aylesworth, C; Bellet, R; Burris, H; Drengler, R; Peacock, N; Ravdin, P; Rodriguez, G; Rowinsky, E; Smith, L; Von Hoff, D; White, L	1
Gradishar, WJ	1
Chan, S	1
al-Tweigeri, T; Au, D; Delorme, F; Mackey, JR; Nabholtz, JM; Noel, D; Paterson, AH; Riva, A; Sansregret, E; Smylie, M	1
Burris, HA	1
Bruno, R; Burris, HA; Chevallier, B; Fossella, FV; Fumoleau, P; Hille, D; Kaye, SB; Ravdin, PM; Rigas, JR; Riva, A; Seidman, AD; Sheiner, LB; ten Bokkel Huinnink, WW; Valero, V; van Oosterom, AT; Verweij, J; Vivier, N	1
de Bruijn, EA; Groult, V; Locci-Tonelli, D; Planting, AS; Pronk, LC; Schellens, JH; Schrijvers, D; van Oosterom, AT; Verweij, J	1
Eisenhauer, EA; Vermorken, JB	1
Dubbelman, R; Hiemstra, A; Lustig, V; Rodenhuis, S; ten Bokkel Huinink, WW	1
Eckhardt, S	1
Booser, DJ; Burris, HA; Earhart, RH; Erban, JK; Esparza-Guerra, L; Holmes, FA; Hortobagyi, GN; Jones, SE; Mennel, RG; Rahman, Z; Ravdin, PM; Schottstaedt, MW; Valero, V; Von Hoff, DD	1
Paridaens, R; Thomas, J; Van Oosterom, A; Van Vaerenbergh, W; Wildiers, J	1
Archer, CD; Coombes, RC; English, J; Khan, S; Lowdell, C; Sinnett, HD	1
de Boer, M; de Wit, R; Kerger, J; Kruit, WH; Stoter, G; Verweij, J	1
Androulakis, N; Chalkiadakis, G; Georgoulias, V; Kakolyris, S; Kourousis, C; Maltezakis, G; Metaxaris, G; Samonis, G; Souglakos, J; Vlachonikolis, J	1
Armand, JP; Couteau, C	1
Baba, S; Ebihara, S; Horiuchi, M; Ichikawa, G; Inuyama, Y; Kamata, S; Kanzaki, J; Kataura, A; Kida, A; Konno, A; Kono, N; Kubota, A; Matsunaga, T; Matsuura, H; Miyake, H; Moriyama, H; Saijo, S; Saito, H; Sakai, M; Sasaki, Y; Satake, B; Taguchi, T; Takeoda, S; Togawa, K; Tsukuda, M	1
Georgoulias, V; Giatromanolaki, A; Kakolyris, S; Koukourakis, MI; Schiza, S	1
Belli, L; Bérille, J; Bougon, N; Douillard, JY; Ibrahim, N; Le Chevalier, T; Monnier, A; Ruffie, P; Sun, XS	1
Androulakis, N; Georgoulias, V; Hatzidaki, D; Kakolyris, S; Katsogridakis, K; Kotsakis, T; Kouroussis, C; Mavroudis, D; Samonis, G; Souglakos, J; Vardakis, N; Vlachonikolis, J	1
Balis, FM; Blaney, SM; Hutchinson, R; Krailo, M; Mosher, RB; O'Brien, M; Reaman, GH; Seibel, NL	1
Aapro, M; Alakl, M; Bezwoda, WR; Deschênes, L; Douma, J; Drbal, J; Genot, JY; Hupperets, PS; Melnychuk, D; Molino, A; Murawsky, M; Nabholtz, JM; Nagykalnai, T; Nortier, JW; Pannuti, F; Rapoport, B; Richel, DJ; Rosso, R; Senn, HJ; Siedlecki, P; Skarlos, D; Tomiak, EM; Trillet-Lenoir, V; Vandenberg, TA; Wilking, N	1
Candalh, E; Kramar, A; Lebecq, A	1
Baccala, P; Berg, D; Clark, JW; Finkelstein, D; Fuchs, CS; Grenon, N; Grossbard, ML; Lynch, TJ; Mayer, RJ; Ryan, DP; Seiden, MV	1
Le Cesne, A; Llombart, A; Rixe, O; Spielmann, M; Sverdlin, R; Zelek, L	1
Lyerly, HK; Morse, MA; Vredenburgh, JJ	1
Alexandre, J; Bensmaïne, A; Bleuzen, P; Bonneterre, J; Chahine, A; Cvitkovic, E; Faivre, S; Guastalla, J; Mahjoubi, M; Marty, M; Misset, JL; Spielman, M; Sutherland, W; Viens, P	1
Bartholomeus, S; Bleiberg, H; Brassinne, C; Cazenave, I; de Valeriola, D; Hennebert, P; Kerger, J; Kusenda, Z; Lefresne-Soulas, F; Piccart, M; Selleslags, J; Van Den Neste, E; Wythouck, H	1
Beijnen, JH; Bult, A; Huizing, MT; Lustig, V; Rodenhuis, S; Rosing, H; Schellens, JH; ten Bokkel Huinink, WW; van Warmerdam, LJ	1
Goto, K; Hojo, F; Hosomi, Y; Kakinuma, R; Kodama, K; Matsumoto, T; Mito, K; Moriyama, E; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Tanaka, K; Uramoto, H	1
de Matteis, A; Landi, G; Nuzzo, F; Perrone, F; Rossi, E	1
Bessa, EH; Lena, H; Paillotin, D; Pérol, M; Robinet, G; Schuller-Lebeau, MP; Taytard, A; Thomas, P; Vergnenègre, A	1
Boukis, H; Janinis, J; Lefantzis, D; Panagos, G; Papadakou, M; Poulis, A; Xidakis, E	1
Carpino, A; Cognetti, F; D'Ottavio, AM; Ferraresi, V; Giannarelli, D; Marsella, A; Milella, M; Nisticò, C; Papaldo, P; Terzoli, E; Thorel, MF; Vaccaro, A	1
Bol, CJ; Palmer, PA; Sparreboom, A; van Beurden, V; van der Burg, ME; van der Gaast, A; van Zuylen, L; Verweij, J; Woestenborghs, R	1
Kris, MG; Miller, VA	1
Bennouna, J; Berille, J; Douillard, JY; Lemarie, E; Milleron, B; Monnier, A; Rivière, A; Soussan-Lazard, K; Trillet-Lenoir, V	1
Androulakis, N; Dimopoulos, MA; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kotsakis, T; Kouroussis, C; Samonis, G; Souglakos, J; Voloudaki, A	1
Chan, CC; Chua, ET; Goh, BC; Kong, HL; Lee, SC; Lehnert, M; Lim, HL; Ng, AW; Wee, J; Wong, JE	1
Gordon, RJ; Osterwalder, B; Planting, AS; Pronk, LC; Reigner, B; Sparreboom, A; Twelves, C; Vasey, P; Verweij, J	1
Halme, M; Jekunen, A; Kivisaari, L; Knuuttila, A; Linnainmaa, K; Mali, P; Mattson, K; Ollikainen, T	1
Fukuoka, M; Kudoh, S; Masuda, N; Nakagawa, K; Negoro, S; Niitani, H; Saka, H; Sugiura, T; Takada, M	1
Agelaki, S; Androulakis, N; Georgoulias, V; Hatzidaki, D; Kakolyris, S; Kalbakis, K; Kourousis, C; Mavroudis, D; Sarmonis, G; Sarra, E; Souglakos, J; Vardakis, N	1
Hansen, HS; Larsen, SK; Specht, L	1
Apostolaki, S; Georgoulias, V; Kotsakis, A; Koukourakis, M; Mavromanomakis, E; Peraki, M; Sarra, E; Souglakos, J; Vlachonikolis, J	1
Bauer, J; Borner, M; Crivellari, D; D'Incalci, M; Goldhirsch, A; Graffeo, R; Hess, D; Lombardi, D; Martinelli, G; Nolè, F; Pagani, O; Sessa, C; Thürlimann, B; Zucchetti, M	1
Fujii, H; Igarashi, T; Itoh, K; Kashimura, M; Minami, H; Ohashi, Y; Ohtsu, T; Onozawa, Y; Sasaki, Y; Wakita, H; Watanabe, Y	1
Blakey, D; Brettell, M; Briggs, P; Chapple, P; Eerhard, S; Gates, P; Januszewicz, EH; Juneja, S; Prince, HM; Quinn, M; Richardson, G; Rischin, D; Scarlett, J; Seymour, JF; Toner, GC; Wolf, M	1
Agelaki, S; Georgoulias, V; Kakolyris, S; Kourousis, CH; Malliotakis, P; Mavroudis, D; Sarra, E; Souglakos, J	1
Agelaki, S; Georgoulias, V; Hatzidaki, D; Kakolyris, S; Kalbakis, K; Kouroussis, C; Mavroudis, D; Reppa, D; Samonis, G; Souglakos, J; Vardakis, N	1
Amodio, A; Belli, F; Botti, C; Conti, F; Di Lauro, L; Ferraironi, A; Foggi, P; Gionfra, T; Lopez, M; Morelli, MF; Vici, P	1
Hirabayashi, K; Hoshiai, H; Katsumata, N; Kohno, I; Noda, K; Ogita, S; Taguchi, T; Tanaka, K; Terashima, Y; Tsunematsu, R; Yakushiji, M	1
Baldelli, AM; Barni, S; Casaretti, R; Cascinu, S; Catalano, G; Catalano, V; Comella, G; Frontini, L; Graziano, F; Labianca, R	1
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K	1
Agelaki, S; Androulakis, N; Bania, E; Chainis, K; Georgoulias, V; Kakolyris, S; Kalofonos, C; Kouroussis, C; Papadakis, E; Rapti, A; Sarra, E; Toubis, M; Tsiafaki, X; Vardakis, N	1
Fleming, GF; Grinblatt, DL; Laport, GG; Waggoner, S; Williams, SF; Zimmerman, TM	1
Athanasiadis, A; Constantinidis, TC; Delis, D; Fachantidou, E; Goutsikas, J; Hatziapostolou, P; Kontakiotis, T; Patakas, D; Zarogoulidis, K	1
Hopkins, U; Malik, U; Rajdev, L; Sarta, C; Sparano, JA; Wolff, AC	1
Minato, K; Mori, M; Saitoh, R; Sato, K; Takei, Y; Tsuchiya, S; Watanabe, S	1
Haga, S; Hirano, A; Imamura, H; Kajiwara, T; Kimura, K; Kinoshita, J; Nagumo, H; Okabe, T; Shimizu, T; Utada, Y; Watanabe, O	1
Pawlicki, M; Rolski, J; Rysz, B; Utych, G; Wiczyńska, B; Zemełka, T	1
Agelaki, S; Alexopoulos, A; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kosmas, C; Kouroussis, C; Malamos, N; Mavroudis, D; Rigatos, G; Sarra, E; Vlachonicolis, J	1
Hada, M; Koshizuka, K; Mouri, N; Muto, S; Nakagomi, H; Serizawa, M; Tada, Y; Takano, K	1
Baker, AF; Dorr, RT	1
Kim, KM; Larson, M; Leu, KM; Schiller, JH	1
Fujimoto, K; Hirai, K; Koizumi, T; Koyama, S; Kubo, K; Nomura, H; Okada, K; Tsunoda, T	1
Beuzeboc, P; Diéras, V; Laurence, V; Pierga, JY; Pouillart, P	1
Carman, L; Colborn, D; Gutterman, L; Jones, J; Kuebler, JP; Larrimer, N; Laufman, LR; Moore, T; Patel, T; Pritchard, J; Roach, R; Segal, M; Spiridonidis, CH; Zangmeister, J	1
Baker, M; Billings, FT; Bradof, JE; Burris, HA; Greco, FA; Hainsworth, JD	1
Bischoff, J; Forstpointner, R; Geuenich, S; Gutschow, K; Heinemann, V; Hiddemann, W; Kentenich, CH; Malekmohammadi, M; Sommer, H; Stemmler, HJ	1
Barbaro, P; Console, G; Iacopino, P; Irrera, G; Martino, M; Messina, G; Morabito, F; Oliva, E; Palazzo, S; Pucci, G	1
Bafaloukos, D; Briassoulis, E; Fountzilas, G; Georgoulias, V; Gogas, H; Kalofonos, Ch; Karabelis, A; Kosmidis, P; Samantas, E; Skarlos, D	1
Doi, S; Fukuda, M; Kanda, T; Kawabata, S; Kinoshita, A; Kohno, S; Nagashima, S; Nakamura, Y; Narasaki, F; Oka, M; Soda, H; Suenaga, M; Takatani, H; Tsurutani, J	1
Goto, K; Kakinuma, R; Kubota, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H	1
Glaspy, J; Hill, LR; Holmes, FA; Jones, SE; Liang, BC; Meza, L; Moore, M; Neumann, TA; O'Shaughnessy, JA; Savin, M; Shogan, J; Vukelja, S; Wiznitzer, I	1
Bougnoux, Ph; Eymard, JC; Lotz, V; Mansouri, H; Namer, M; Spielmann, M; Tubiana-Hulin, M; Tubiana-Mathieu, N	1
Forastiere, AA; Frenette, G; Glisson, BS; Khuri, FR; Murphy, BA	1
Botti, G; D'Aiuto, G; De Maio, E; de Matteis, A; Labonia, V; Landi, G; Mastro, AA; Nuzzo, F; Perrone, F; Rossi, E	1
Angiolini, C; Baldini, A; Bergaglio, M; Canavese, G; Del Mastro, L; Garrone, O; Lambiase, A; Merlano, M; Rosso, R; Tolino, G; Venturini, M	1
Aghajanian, C; Barakat, R; Geller, G; Hensley, ML; Lovegren, M; Maki, R; Sabbatini, P; Spriggs, DR; Tong, W; Venkatraman, E	1
Alexopoulou, A; Deutsch, M; Dourakis, SP; Sevastianos, VA; Stavrianeas, N	1

Reviews

34 review(s) available for docetaxel anhydrous and Neutropenia

Article	Year
Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. The Cochrane database of systematic reviews, 2019, 02-18, Volume: 2 Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Neoadjuvant Therapy; Nervous System; Neutropenia; Paclitaxel; Quality of Life; Randomized Controlled Trials as Topic; Taxoids	2019
Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort. Cancer medicine, 2019, Volume: 8, Issue:4 Topics: Area Under Curve; Clinical Trials as Topic; Docetaxel; Humans; Incidence; Logistic Models; Male; Neoplasm Metastasis; Neoplasms; Neutropenia; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome	2019
Taxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicity. Critical reviews in oncology/hematology, 2014, Volume: 91, Issue:3 Topics: Antineoplastic Agents; Biomarkers, Tumor; Clinical Trials as Topic; Docetaxel; Humans; Male; Neutropenia; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Survival Analysis; Taxoids	2014
Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:7 Topics: Antineoplastic Agents; Camptothecin; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Deoxycytidine; Docetaxel; Enzyme Induction; Erlotinib Hydrochloride; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Neutropenia; Nicotine; Paclitaxel; Polycyclic Aromatic Hydrocarbons; Quinazolines; Smoking; Taxoids	2014
Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:3 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Neutropenia; Prognosis; Survival Rate; Taxoids	2016
The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis. British journal of cancer, 2009, Feb-10, Volume: 100, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Fever; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Risk Factors; Taxoids	2009
Docetaxel-related side effects and their management. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2009, Volume: 13, Issue:1 Topics: Antineoplastic Agents; Asthenia; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Monitoring; Edema; Evidence-Based Practice; Humans; Nail Diseases; Neoplasms; Nervous System Diseases; Neutropenia; Nursing Assessment; Oncology Nursing; Patient Selection; Practice Guidelines as Topic; Quality of Life; Severity of Illness Index; Taxoids	2009
Critical appraisal of cabazitaxel in the management of advanced prostate cancer. Clinical interventions in aging, 2010, Dec-03, Volume: 5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Male; Mice; Neutropenia; Prednisone; Prostatic Neoplasms; Rats; Taxoids	2010
Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials. International journal of clinical oncology, 2013, Volume: 18, Issue:1 Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Dose-Response Relationship, Drug; Ethnicity; Humans; Neoplasms; Neutropenia; Taxoids	2013
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Docetaxel; Epirubicin; Fever; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Taxoids	2012
[Prevention and treatment for adverse events induced by chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:7 Topics: Anaphylaxis; Antineoplastic Agents; Brain Diseases; Cisplatin; Docetaxel; Fluorouracil; Humans; Neoplasms; Neutropenia; Paclitaxel; Taxoids; Vomiting, Anticipatory	2002
Challenging the platinum combinations in the chemotherapy of NSCLC. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38 Suppl 4 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Neutropenia; Paclitaxel; Taxoids	2002
Managing taxane toxicities. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Arthralgia; Bridged-Ring Compounds; Docetaxel; Drug Hypersensitivity; Humans; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Taxoids; Thrombocytopenia	2003
Filgrastim-mediated neutrophil recovery in patients with breast cancer treated with docetaxel and doxorubicin. Pharmacotherapy, 2003, Volume: 23, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Neutrophils; Recombinant Proteins; Taxoids; Time Factors	2003
Practical aspects of weekly docetaxel administration schedules. The oncologist, 2004, Volume: 9, Issue:5 Topics: Age Factors; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Fatigue; Humans; Infusions, Intravenous; Neoplasms; Neutropenia; Palliative Care; Taxoids	2004
A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma. Oral oncology, 2005, Volume: 41, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2005
[The role of taxanes for head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Neutropenia; Taxoids	2005
Hematopoietic support with moderately myelosuppressive chemotherapy regimens: a nursing perspective. Clinical journal of oncology nursing, 2006, Volume: 10, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Docetaxel; Drug Therapy, Combination; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids	2006
[Combination chemotherapy of S-1 plus biweekly docetaxel for advanced and recurrent gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 1 Topics: Animals; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Combinations; Humans; Leukopenia; Neoplasm Transplantation; Neutropenia; Oxonic Acid; Quality of Life; Randomized Controlled Trials as Topic; Rats; Rats, Nude; Stomach Neoplasms; Stomatitis; Taxoids; Tegafur	2006
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Cancer treatment reviews, 2006, Volume: 32, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Humans; Infusions, Intravenous; Lung Neoplasms; Neoplasm Staging; Neutropenia; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids	2006
Docetaxel-related side effects and their management. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2008, Volume: 12, Issue:3 Topics: Antineoplastic Agents; Asthenia; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Monitoring; Evidence-Based Medicine; Fever; Humans; Nail Diseases; Neutropenia; Nurse's Role; Nursing Assessment; Nursing Research; Oncology Nursing; Patient Education as Topic; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Premedication; Research Design; Severity of Illness Index; Taxoids; Water-Electrolyte Imbalance	2008
[Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy]. Bulletin du cancer, 1995, Volume: 82, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Tolerance; Female; Humans; Male; Neoplasms; Neutropenia; Organoplatinum Compounds; Paclitaxel; Taxoids	1995
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. International journal of clinical & laboratory research, 1994, Volume: 24, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Arrhythmias, Cardiac; Cell Cycle; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Hypersensitivity; Drug Screening Assays, Antitumor; Gastrointestinal Diseases; Humans; Mice; Microtubules; Neoplasms; Neoplasms, Experimental; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Polyethylene Glycols; Taxoids; Tubulin	1994
[Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]. Bulletin du cancer, 1996, Volume: 83, Issue:1 Topics: Antidiarrheals; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Humans; Irinotecan; Loperamide; Male; Neoplasms; Neutropenia; Paclitaxel; Remission Induction; Taxoids; Topoisomerase I Inhibitors	1996
Docetaxel: a review of its pharmacology and clinical activity. The Canadian journal of oncology, 1996, Volume: 6, Issue:1 Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Division; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Eruptions; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Microtubules; Neutropenia; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Taxoids; Tubulin	1996
Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy. Seminars in oncology, 1997, Volume: 24, Issue:4 Suppl 13 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials as Topic; Docetaxel; Female; Humans; Neoplasm Metastasis; Neutropenia; Paclitaxel; Taxoids	1997
Review of docetaxel/doxorubicin combination in metastatic breast cancer. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1997
Docetaxel in combination with fluorouracil for advanced solid tumors. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adult; Aged; Animals; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Mice; Middle Aged; Mucous Membrane; Neoplasms; Neutropenia; Paclitaxel; Taxoids	1997
The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs, 1998, Volume: 55, Issue:1 Topics: Alopecia; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase I as Topic; Docetaxel; Female; Humans; Lung Neoplasms; Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids	1998
[The effect of docetaxel on malignant tumors]. Orvosi hetilap, 1998, Apr-12, Volume: 139, Issue:15 Topics: Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Humans; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1998
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas]. Bulletin du cancer, 1998, Volume: Spec No Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diarrhea; Docetaxel; Enzyme Inhibitors; Etoposide; Female; Genital Neoplasms, Female; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Neoplasms; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome	1998
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer. Seminars in oncology, 2000, Volume: 27, Issue:2 Suppl 3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2000
Drug interactions with the taxanes: clinical implications. Cancer treatment reviews, 2001, Volume: 27, Issue:4 Topics: Anticonvulsants; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Interactions; Humans; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia	2001
Interaction between Herceptin and taxanes. Oncology, 2001, Volume: 61 Suppl 2 Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Heart Diseases; Humans; Mice; Mice, Nude; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Nervous System Diseases; Neutropenia; Paclitaxel; Palliative Care; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptor, ErbB-3; Salvage Therapy; Survival Analysis; Taxoids; Trastuzumab; Treatment Outcome; Xenograft Model Antitumor Assays	2001

Trials

320 trial(s) available for docetaxel anhydrous and Neutropenia

Article	Year
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer. BMC cancer, 2021, Oct-01, Volume: 21, Issue:1 Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fatigue; Feasibility Studies; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Oxonic Acid; Patient Compliance; Stomach Neoplasms; Tegafur	2021
A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer. BMC cancer, 2021, Nov-29, Volume: 21, Issue:1 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anemia; Antineoplastic Agents; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fatigue; Follow-Up Studies; Humans; Male; Middle Aged; Nail Diseases; Neutropenia; Pneumonia; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomatitis	2021
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial. JAMA network open, 2022, 01-04, Volume: 5, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Diketopiperazines; Docetaxel; Double-Blind Method; Female; Filgrastim; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Polyethylene Glycols; Prostatic Neoplasms; Treatment Outcome	2022
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. The New England journal of medicine, 2022, 03-24, Volume: 386, Issue:12 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents; Docetaxel; Drug Therapy, Combination; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Proportional Hazards Models; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pyrazoles	2022
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study. The Lancet. Oncology, 2022, Volume: 23, Issue:11 Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Double-Blind Method; Humans; Male; Neutropenia; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome	2022
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study. Cancer medicine, 2023, Volume: 12, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Neutropenia; Receptor, ErbB-2; Stomach Neoplasms	2023
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma. BMC cancer, 2023, Jul-08, Volume: 23, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Quality of Life; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Treatment Outcome	2023
A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01. Thoracic cancer, 2023, Volume: 14, Issue:29 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lung Neoplasms; Neutropenia; Taxoids; Treatment Outcome	2023
Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study. Cancer science, 2019, Volume: 110, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Filgrastim; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Prospective Studies	2019
A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study. Cancer medicine, 2020, Volume: 9, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Febrile Neutropenia; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Agents; Humans; Immunoglobulin Fc Fragments; Middle Aged; Neutropenia; Polyethylene Glycols	2020
Justification for a Fixed Dose of Eflapegrastim, a Long-Acting G-CSF, in Patients Receiving Docetaxel-Cyclophosphamide Chemotherapy. Journal of clinical pharmacology, 2021, Volume: 61, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Half-Life; Hematologic Agents; Humans; Immunoglobulin Fc Fragments; Metabolic Clearance Rate; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols	2021
Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety. International journal of clinical oncology, 2017, Volume: 22, Issue:5 Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; Carboplatin; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Receptor, ErbB-2; Taxoids; Trastuzumab	2017
Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase III, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppres Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 01-01, Volume: 29, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast Neoplasms; Cyclophosphamide; Docetaxel; Double-Blind Method; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Humans; Middle Aged; Neutropenia; Young Adult	2018
Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study. Clinical genitourinary cancer, 2018, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Platinum Compounds; Progression-Free Survival; Response Evaluation Criteria in Solid Tumors; Urologic Neoplasms	2018
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy. BMC cancer, 2019, Feb-06, Volume: 19, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast Neoplasms; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Hematologic Agents; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Polyethylene Glycols; Therapeutic Equivalency	2019
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. International journal of clinical oncology, 2019, Volume: 24, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Oxonic Acid; Quality of Life; Tegafur; Treatment Outcome	2019
A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. Oncology research and treatment, 2019, Volume: 42, Issue:5 Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Maximum Tolerated Dose; Middle Aged; Nausea; Neoadjuvant Therapy; Neutropenia; Pilot Projects; Polyethylene Glycols; Stomatitis; Treatment Outcome	2019
Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system. PloS one, 2019, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Neutrophils	2019
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, May-10, Volume: 31, Issue:14 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Hypertension; Inflammatory Breast Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Quality of Life; Receptor, ErbB-2; Surveys and Questionnaires; Taxoids; Trastuzumab; Treatment Outcome; Vascular Endothelial Growth Factor A	2013
[Prevention of neutropenia during adjuvant taxotere therapy for breast cancer]. Voprosy onkologii, 2012, Volume: 58, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caproates; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Hematologic Agents; Humans; Imidazoles; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Taxoids; Treatment Outcome	2012
[Cisplatin-based chronotherapy for advanced none-small cell lung cancer: a randomized controlled study]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Drug Chronotherapy; Female; Gemcitabine; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Taxoids	2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. Investigational new drugs, 2013, Volume: 31, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids; Treatment Outcome	2013
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Severity of Illness Index; Taxoids; Tubulin Modulators	2013
Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma. International journal of clinical oncology, 2014, Volume: 19, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Taxoids; Thrombocytopenia; Treatment Outcome; Urologic Neoplasms; Urothelium; Young Adult	2014
Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy. BMC cancer, 2013, Aug-14, Volume: 13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Polyethylene Glycols; Prognosis; Recombinant Proteins; Taxoids	2013
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Gemcitabine; Hand-Foot Syndrome; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pyrroles; Sunitinib; Survival Rate; Taxoids; Thrombocytopenia; Triple Negative Breast Neoplasms	2013
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC). Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:5 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Humans; Intention to Treat Analysis; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Survival Analysis; Taxoids	2013
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diarrhea; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Neutropenia; Receptor, ErbB-2; Survival Rate; Taxoids; Thrombocytopenia; Young Adult	2013
Phase II trial of biweekly chemotherapy with docetaxel and cisplatin in high-risk patients with unresectable non-small cell lung cancer. Chemotherapy, 2013, Volume: 59, Issue:3 Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Diarrhea; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2013
Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nausea; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
[Efficacy and safety of rh-endostatin combined with docetaxel in second-line or intolerant toxicity for first-line treatment in patients with advanced non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Double-Blind Method; Endostatins; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids	2013
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment. American journal of clinical oncology, 2016, Volume: 39, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Taxoids; Treatment Failure; Vomiting	2016
Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Chemistry, Pharmaceutical; Cross-Over Studies; Docetaxel; Drug Delivery Systems; Female; Humans; Injections; Male; Middle Aged; Neoplasms; Neutropenia; Polysorbates; Taxoids	2014
Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed. British journal of cancer, 2014, May-13, Volume: 110, Issue:10 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Humans; Infusions, Intravenous; Inhibitory Concentration 50; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Taxoids; Thrombocytopenia; Treatment Outcome	2014
Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2). International journal of radiation oncology, biology, physics, 2014, Jul-15, Volume: 89, Issue:4 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagitis; Feasibility Studies; Febrile Neutropenia; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiotherapy Dosage; Taxoids	2014
A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy. Breast cancer research and treatment, 2014, Volume: 148, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids	2014
Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast; Breast Neoplasms; Cohort Studies; Deoxycytidine; Docetaxel; Drug Monitoring; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Salvage Therapy; Survival Analysis; Taxoids	2015
Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer. Annals of surgical oncology, 2015, Volume: 22, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Prospective Studies; Survival Rate; Taxoids; Treatment Outcome	2015
Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids	2015
A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer. International journal of radiation oncology, biology, physics, 2015, Oct-01, Volume: 93, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagitis; Feasibility Studies; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Pneumonia; Radiotherapy Dosage; Stomatitis; Taxoids	2015
Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug-drug interaction. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Follow-Up Studies; Gefitinib; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Neutropenia; Patient Dropouts; Quinazolines; Taxoids	2015
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Palliative Care; Spain; Stomach Neoplasms; Survival Analysis; Taxoids	2015
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. The New England journal of medicine, 2015, Aug-20, Volume: 373, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Docetaxel; Drug Therapy, Combination; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids	2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6 Topics: Adolescent; Anemia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Child; Child, Preschool; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Quinolines; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting	2015
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial. The Lancet. Oncology, 2016, Volume: 17, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Drug Combinations; Edema; Fatigue; Female; Follow-Up Studies; Health Status; Humans; Liver Neoplasms; Middle Aged; Neutropenia; Oxonic Acid; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Tegafur	2016
Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2017, 02-01, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Research Design; Taxoids; Treatment Outcome	2017
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, Volume: 38, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Induction Chemotherapy; Lung Neoplasms; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids	2016
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:3 Topics: Acrylamides; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dimerization; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Middle Aged; Neoplasms; Neutropenia; Nitric Oxide Synthase Type II; Pyrimidines; Taxoids; Xenograft Model Antitumor Assays	2016
Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial. European journal of cancer (Oxford, England : 1990), 2016, Volume: 56 Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Granulocyte Colony-Stimulating Factor; Humans; Kallikreins; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocytes; Male; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Neutrophils; Prednisone; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Risk Factors; Severity of Illness Index; Taxoids; Time Factors; Treatment Outcome	2016
Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus. Anticancer research, 2016, Volume: 36, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Feasibility Studies; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Risk Factors; Taxoids; Time Factors; Treatment Outcome	2016
Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma. Cancer science, 2016, Volume: 107, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxonic Acid; Taxoids; Tegafur; Treatment Outcome	2016
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Early Termination of Clinical Trials; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Dosage; Severity of Illness Index; Taxoids	2016
Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix. International journal of clinical oncology, 2016, Volume: 21, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Prognosis; Survival Rate; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms	2016
Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:12 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Asian People; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Gingivitis; Half-Life; Humans; Japan; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Ramucirumab; Receptor, ErbB-2; Taxoids; Treatment Outcome	2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer. Clinical breast cancer, 2017, Volume: 17, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Quality of Life; Receptor, ErbB-2; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2017
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer. Oncotarget, 2017, Jan-10, Volume: 8, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Tetrahydronaphthalenes; Triple Negative Breast Neoplasms; Valine; Vomiting	2017
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:10 Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Darbepoetin alfa; Docetaxel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematinics; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Mesna; Middle Aged; Neoplasm Staging; Neutropenia; Polyethylene Glycols; Prognosis; Recombinant Proteins; Survival Rate; Taxoids	2008
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cohort Studies; Dacarbazine; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Staging; Neutropenia; Pulmonary Embolism; Skin Neoplasms; Taxoids; Temozolomide; Treatment Outcome	2009
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy. BMC cancer, 2008, Nov-12, Volume: 8 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Neutrophils; Recombinant Proteins; Taxoids; Treatment Outcome	2008
Phase II study of dose-dense doxorubicin and docetaxel as neoadjunvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Asthenia; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Docetaxel; Doxorubicin; Drug Eruptions; Female; Granulocyte Colony-Stimulating Factor; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neutropenia; Prospective Studies; Stomatitis; Taxoids	2008
[A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Doxorubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Remission Induction; Salvage Therapy; Taxoids; Treatment Failure; Vomiting	2008
[Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:7 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids; Young Adult	2008
Pharmacogenetic analyses of hematotoxicity in advanced gastric cancer patients receiving biweekly fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; DNA Primers; DNA Repair; Docetaxel; Fluorouracil; Humans; Leucovorin; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Genetic; Taxoids	2009
Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results. Anti-cancer drugs, 2009, Volume: 20, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Taxoids; Treatment Outcome	2009
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. Lancet (London, England), 2009, May-16, Volume: 373, Issue:9676 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Belgium; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Early Diagnosis; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lethargy; Leukopenia; Middle Aged; Neutropenia; Proportional Hazards Models; Receptors, Estrogen; Taxoids; Treatment Outcome; United Kingdom	2009
Clinical trial simulations for dosage optimization of docetaxel in patients with liver dysfunction, based on a log-binominal regression for febrile neutropenia. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Feasibility Studies; Fever; Humans; Infusions, Intravenous; Liver Diseases; Lung Neoplasms; Metabolic Clearance Rate; Monte Carlo Method; Neutropenia; Taxoids	2009
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fever; Fluorouracil; Humans; Lymph Nodes; Middle Aged; Mucositis; Neutropenia; Prospective Studies; Receptor, ErbB-2; Survival Analysis; Taxoids	2010
Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:3 Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Docetaxel; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neutropenia; Organoplatinum Compounds; Prospective Studies; Taxoids; Treatment Outcome; Young Adult	2010
[Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Mucositis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids; Young Adult	2009
Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 68, Issue:3 Topics: Administration, Oral; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Drug Combinations; Drug Dosage Calculations; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxonic Acid; Survival Analysis; Taxoids; Tegafur	2010
A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Squamous Cell; Neutropenia; Taxoids	2010
Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 69, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Infections; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Survival Analysis; Taxoids	2010
Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mucositis; Nasopharyngeal Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Taxoids; Treatment Outcome	2010
[Equalization of breast cancer chemotherapy at general hospital( II )-evaluation of safety in FEC and TC regimens]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Ciprofloxacin; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Hospitals, General; Humans; Japan; Middle Aged; Neutropenia; Taxoids	2009
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer biology & therapy, 2010, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Curcumin; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids; Time Factors; Treatment Outcome	2010
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Neutropenia; Taxoids	2010
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 69, Issue:2 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Disease Progression; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quality of Life; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	2010
Development of a new G-CSF product based on biosimilarity assessment. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Over Studies; Docetaxel; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Recombinant Proteins; Survival Rate; Taxoids; Treatment Outcome; Young Adult	2010
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neutropenia; Oxonic Acid; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome	2010
Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Oxonic Acid; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2010
Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study. Anti-cancer drugs, 2010, Volume: 21, Issue:3 Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Brain Injuries; Canada; Cerebral Infarction; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Mesna; Middle Aged; Neoplasms; Neutropenia; Taxoids; Thrombocytopenia	2010
Phase I study of TPF neoadjuvant chemotherapy followed by radical radiotherapy in advanced nasopharyngeal carcinoma. Chinese journal of cancer, 2010, Volume: 29, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mucositis; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Radiotherapy, High-Energy; Taxoids	2010
Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin. Chinese journal of cancer, 2010, Volume: 29, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Survival Rate; Taxoids; Thrombocytopenia; Vomiting	2010
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diarrhea; Docetaxel; ErbB Receptors; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Prognosis; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Tissue Array Analysis; Treatment Outcome	2010
A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma. Chinese journal of cancer, 2010, Volume: 29, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Taxoids; Thrombocytopenia	2010
Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2010, Volume: 23, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Drug Administration Schedule; Drug Interactions; Esophageal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Taxoids; Treatment Outcome	2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. British journal of cancer, 2010, Jul-27, Volume: 103, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cellulitis; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulins, Intravenous; Lymphopenia; Male; Middle Aged; Neoplasms; Neutropenia; Prostatic Neoplasms; Receptor, IGF Type 1; Taxoids	2010
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial. Cancer biology & therapy, 2010, Sep-15, Volume: 10, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Fever; Humans; Imidazoles; Infusions, Intravenous; Interleukin-8; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neutropenia; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome; Zoledronic Acid	2010
Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-20, Volume: 28, Issue:30 Topics: Animals; Antineoplastic Agents; Baltimore; Biological Transport; Biotransformation; Breath Tests; Cell Line; Cytochrome P-450 CYP3A; Docetaxel; Hepatocytes; Humans; Liver; Male; Neutropenia; Orchiectomy; Organic Anion Transporters, Sodium-Independent; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Taxoids; Transfection; Treatment Outcome	2010
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet (London, England), 2010, Oct-02, Volume: 376, Issue:9747 Topics: Administration, Oral; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Mitoxantrone; Neutropenia; Pain Measurement; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Failure; Treatment Outcome	2010
Poor survival outcome of docetaxel every three weeks plus prednisone for treatment of patients with hormone-refractory metastatic prostate cancer. Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:3 Topics: Aged; Alopecia; Anemia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Prednisone; Prospective Studies; Prostatic Neoplasms; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome	2010
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Folic Acid Antagonists; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neutropenia; Pemetrexed; Taxoids; Tubulin Modulators; Tumor Burden	2011
[Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:11 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pemetrexed; Platinum; Protein Kinase Inhibitors; Quinazolines; Remission Induction; Salvage Therapy; Taxoids; Treatment Failure	2010
Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer. The Prostate, 2011, Volume: 71, Issue:12 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Cohort Studies; Docetaxel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Orchiectomy; Pain; Prostatic Neoplasms; Pyrrolidines; Taxoids; Treatment Outcome	2011
Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group. Lung cancer (Amsterdam, Netherlands), 2011, Volume: 73, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Protocols; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neutropenia; Quality of Life; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome	2011
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel. Investigational new drugs, 2012, Volume: 30, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Diarrhea; Diketopiperazines; Docetaxel; Fatigue; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Pain; Taxoids; Vomiting	2012
A phase I study of bi-weekly docetaxel for recurrent or advanced gastric cancer patients whose disease progressed by prior chemotherapy. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:6 Topics: Adult; Aged; Alanine Transaminase; Anemia; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Patient Selection; Salvage Therapy; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome	2011
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Hypertension; Imidazoles; Indazoles; Middle Aged; Mucositis; Neoplasm Proteins; Neutropenia; Protein Kinase Inhibitors; Receptors, Vascular Endothelial Growth Factor; Taxoids; Thrombophilia	2011
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Pancreatic Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2012
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Muscles; Nausea; Neoplasm Invasiveness; Neoplasm Staging; Neutropenia; Taxoids; Thrombocytopenia; Treatment Outcome; Urinary Bladder Neoplasms	2012
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2012
Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer. Oncology, 2011, Volume: 80, Issue:5-6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome	2011
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Fatigue; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Taxoids; Treatment Outcome	2012
The safety and tolerability of intravenous ASA404 when administered in combination with docetaxel (60 or 75 mg/m²) in Japanese patients with advanced or recurrent solid tumors. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:9 Topics: Aged; Alopecia; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Appetite; Asian People; Constipation; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Severity of Illness Index; Taxoids; Treatment Outcome; Xanthones	2011
A lower dose of docetaxel at 60 mg/m(2) could be continued longer for controlling peripheral edema in patients with metastatic breast cancer. Breast cancer (Tokyo, Japan), 2012, Volume: 19, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Dexamethasone; Diuretics; Docetaxel; Dose-Response Relationship, Drug; Edema; Female; Follow-Up Studies; Humans; Middle Aged; Neutropenia; Retrospective Studies; Taxoids; Treatment Outcome	2012
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Diarrhea; Disease-Free Survival; Docetaxel; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mucositis; Neutropenia; Quinazolines; Taxoids	2011
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer, 2012, May-01, Volume: 118, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Early Termination of Clinical Trials; Everolimus; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Sirolimus; Taxoids	2012
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Double-Blind Method; Dyspnea; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Leukopenia; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Neutropenia; Ofloxacin; Pain; Taxoids	2011
An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. Medicina (Kaunas, Lithuania), 2011, Volume: 47, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Recombinant Proteins; Taxoids; Treatment Outcome	2011
Phase I dose-escalation study of intravenous aflibercept in combination with docetaxel in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-15, Volume: 18, Issue:6 Topics: Adult; Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids	2012
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:5 Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Cytochrome P-450 CYP3A; Docetaxel; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neutropenia; Organic Anion Transporters, Sodium-Independent; Pharmacogenetics; Polymorphism, Single Nucleotide; Prospective Studies; Republic of Korea; Retrospective Studies; Solute Carrier Organic Anion Transporter Family Member 1B3; Taxoids	2012
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial. Cancer, 2012, Oct-01, Volume: 118, Issue:19 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Docetaxel; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neutropenia; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Risk Assessment; Risk Factors; Taxoids; Treatment Outcome	2012
[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France]. Bulletin du cancer, 2012, Volume: 99, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Docetaxel; Female; Hemorrhage; Humans; Hypertension; Middle Aged; Neutropenia; Paclitaxel; Proteinuria; Taxoids; Thromboembolism; Young Adult	2012
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:1 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Fluorouracil; Hand-Foot Syndrome; Humans; Middle Aged; Neoplasm Metastasis; Nervous System Diseases; Neutropenia; Remission Induction; Salvage Therapy; Taxoids; Treatment Outcome	2012
Feasibility of prior administration of cyclophosphamide in TC combination treatment. Breast cancer (Tokyo, Japan), 2014, Volume: 21, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diarrhea; Docetaxel; Drug Administration Schedule; Eczema; Female; Humans; Middle Aged; Neutropenia; Prospective Studies; Taxoids; Treatment Outcome	2014
Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer. Anti-cancer drugs, 2012, Volume: 23, Issue:7 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2012
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours. British journal of cancer, 2012, Aug-07, Volume: 107, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Fatigue; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids	2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure. BJU international, 2013, Volume: 111, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Aurora Kinases; Benzamides; Bone Neoplasms; Castration; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Pyrazoles; Taxoids; Treatment Failure	2013
[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:6 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Premenopause; Radiotherapy, Adjuvant; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vomiting	2012
Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. Clinical genitourinary cancer, 2012, Volume: 10, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Gossypol; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neutropenia; Prednisone; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Survival Analysis; Taxoids	2012
Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel. PloS one, 2012, Volume: 7, Issue:10 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dexamethasone; Docetaxel; Drug Resistance, Neoplasm; Humans; Kaplan-Meier Estimate; Long-Term Care; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Taxoids; Treatment Outcome	2012
Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study. Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:6 Topics: Aged; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Dehydration; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2012
[Comparison between docetaxel plus cisplatin and cisplatin plus fluorouracil in the neoadjuvant chemoradiotherapy for local advanced esophageal squamous cell carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Radiotherapy, High-Energy; Remission Induction; Taxoids; Vomiting	2012
Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis. Breast cancer (Tokyo, Japan), 2014, Volume: 21, Issue:6 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Neutropenia; Quality of Life; Taxoids; Treatment Outcome	2014
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Confidence Intervals; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Middle Aged; Neutropenia; Paclitaxel; Polyethylene Glycols; Probability; Recombinant Proteins; Reference Values; Taxoids; Treatment Outcome	2002
A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study. Oncology, 2002, Volume: 62, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2002
A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Oral oncology, 2002, Volume: 38, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2002
Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial. Japanese journal of clinical oncology, 2002, Volume: 32, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Docetaxel; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids	2002
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cost Control; Deoxycytidine; Disease Progression; Docetaxel; Drug Costs; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival; Taxoids; Treatment Outcome	2002
Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; Incidence; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Taxoids; Time Factors; Treatment Outcome	2002
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer. Oncology, 2002, Volume: 63, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids	2002
Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38, Issue:2 Topics: Age Factors; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Humans; Infections; Lung Neoplasms; Male; Neutropenia; Paclitaxel; Taxoids	2002
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. Clinical breast cancer, 2002, Volume: 3, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-3; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Recombinant Fusion Proteins; Recombinant Proteins; Taxoids; Treatment Outcome	2002
Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure. British journal of cancer, 2002, Nov-18, Volume: 87, Issue:11 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Infections; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Palliative Care; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2002
Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Docetaxel; Double-Blind Method; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Neutrophils; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Taxoids	2003
A phase I study of carboplatin and docetaxel for advanced non-small cell lung cancer using the continual reassessment method. Japanese journal of clinical oncology, 2002, Volume: 32, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Lung Neoplasms; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia	2002
A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival Analysis; Taxoids	2003
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carboplatin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Docetaxel; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Taxoids; White People	2003
Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors. Medical oncology (Northwood, London, England), 2003, Volume: 20, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Recombinant Proteins; Salvage Therapy; Taxoids; Treatment Outcome	2003
Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Pulmonary Fibrosis; Survival Analysis; Taxoids; Treatment Outcome	2003
Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer. Acta oncologica (Stockholm, Sweden), 2003, Volume: 42, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Docetaxel; Drug Interactions; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2003
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study. Breast cancer research and treatment, 2003, Volume: 80, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Nausea; Neutropenia; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting	2003
Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer: preliminary results. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 42, Issue:2 Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Enoxaparin; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma. Cancer, 2003, Nov-01, Volume: 98, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms	2003
A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma. Cancer, 2003, Nov-01, Volume: 98, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Capecitabine; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Stomatitis; Survival Analysis; Taxoids; Treatment Outcome	2003
Filgrastim-mediated neutrophil recovery in patients with breast cancer treated with docetaxel and doxorubicin. Pharmacotherapy, 2003, Volume: 23, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Neutrophils; Recombinant Proteins; Taxoids; Time Factors	2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jan-15, Volume: 22, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Methotrexate; Middle Aged; Neutropenia; Prognosis; Taxoids; Thrombocytopenia; Treatment Outcome; Urologic Neoplasms; Vinblastine	2004
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Safety; Survival Analysis; Taxoids; Time Factors; Treatment Failure; Treatment Outcome	2004
Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803). British journal of cancer, 2004, Jan-12, Volume: 90, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Diarrhea; Docetaxel; Female; Humans; Infusions, Intravenous; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Survival Analysis; Taxoids; Vomiting	2004
A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Colony-Forming Units Assay; Docetaxel; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Middle Aged; Neutropenia; Taxoids; Treatment Outcome	2004
A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer. British journal of cancer, 2004, Apr-05, Volume: 90, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Feasibility Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids	2004
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, May-01, Volume: 22, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pemetrexed; Survival Analysis; Taxoids; Treatment Outcome	2004
Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Taxoids	2004
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Fever; Health Status; Humans; Lung Neoplasms; Male; Neutropenia; Taxoids; Treatment Outcome	2004
Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. International journal of radiation oncology, biology, physics, 2004, Jun-01, Volume: 59, Issue:2 Topics: Adult; Aged; Anemia; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Radiotherapy Dosage; Stomatitis; Taxoids; Thrombocytopenia	2004
Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study. British journal of cancer, 2004, Jun-01, Volume: 90, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2004
A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:6 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2004
Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel. Acta oncologica (Stockholm, Sweden), 2004, Volume: 43, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Female; Humans; Infections; Leukocyte Count; Middle Aged; Mouth Mucosa; Mucous Membrane; Neutropenia; Regression Analysis; Skin; Taxoids	2004
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer. British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Male; Middle Aged; Neutropenia; Palliative Care; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2004
Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2004, Volume: 45, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Docetaxel; Female; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids	2004
A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Diarrhea; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Squamous Cell; Neutropenia; Organoplatinum Compounds; Prostatic Neoplasms; Taxoids; Treatment Outcome	2004
Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-01, Volume: 22, Issue:13 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Fever; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids; Treatment Outcome	2004
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study. British journal of cancer, 2004, Aug-02, Volume: 91, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quality of Life; Survival Analysis; Taxoids	2004
Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-15, Volume: 22, Issue:14 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Middle Aged; Neutropenia; Taxoids; Treatment Outcome	2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:9 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Asthenia; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Europe; Female; Humans; Infusions, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neutropenia; Prospective Studies; Survival Analysis; Taxoids; Treatment Outcome	2004
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Oct-15, Volume: 10, Issue:20 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neoadjuvant Therapy; Neutropenia; Peripheral Nervous System Diseases; Taxoids; Treatment Outcome	2004
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. Journal of the National Cancer Institute, 2004, Nov-17, Volume: 96, Issue:22 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Confidence Intervals; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neutropenia; Odds Ratio; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Peritoneal Neoplasms; Proportional Hazards Models; Quality of Life; Survival Analysis; Taxoids; Treatment Outcome	2004
Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study. International journal of clinical oncology, 2004, Volume: 9, Issue:5 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2004
Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma. Cancer investigation, 2004, Volume: 22, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neutropenia; Pancreatic Neoplasms; Survival Rate; Taxoids	2004
Docetaxel and cisplatin as primary chemotherapy for treatment of locally advanced breast cancers. Clinical breast cancer, 2004, Volume: 5, Issue:5 Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Radiography; Taxoids; Treatment Outcome	2004
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer. Clinical breast cancer, 2004, Volume: 5, Issue:5 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Breast Neoplasms; Combined Modality Therapy; Docetaxel; Doxorubicin; Female; Follow-Up Studies; Heart; Humans; Hypersensitivity; Kidney; Liver; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nerve Tissue; Neutropenia; Radiography; Taxoids; Treatment Outcome	2004
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cross-Over Studies; Disease Progression; Docetaxel; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	2005
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Asthenia; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Survival Analysis; Taxoids; Vomiting	2005
Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. Anti-cancer drugs, 2005, Volume: 16, Issue:1 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Hematologic Agents; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Taxoids; Time Factors; Treatment Failure; Treatment Outcome; Vinblastine; Vinorelbine	2005
Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 47, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Tumor Cells, Cultured	2005
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma. Cancer chemotherapy and pharmacology, 2005, Volume: 55, Issue:5 Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Survival Rate; Taxoids	2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Infections; Male; Methotrexate; Middle Aged; Neutropenia; Prognosis; Survival Analysis; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine	2005
Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Middle Aged; Neoplasms; Neutropenia; Taxoids	2005
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Double-Blind Method; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Placebos; Polyethylene Glycols; Recombinant Proteins; Taxoids	2005
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer. Oncology, 2005, Volume: 68, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Prospective Studies; Severity of Illness Index; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome	2005
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-20, Volume: 23, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Mastectomy, Segmental; Middle Aged; Neutropenia; Taxoids; Treatment Outcome	2005
Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:5 Topics: Adult; Aged; Anemia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Camptothecin; Disease Progression; Disease-Free Survival; Docetaxel; Female; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neutropenia; Taxoids	2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-01, Volume: 23, Issue:19 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Neoplasm Metastasis; Neutropenia; Receptor, ErbB-2; Taxoids; Trastuzumab	2005
A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma. Oral oncology, 2005, Volume: 41, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2005
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 50, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2005
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor. Oncology reports, 2005, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diarrhea; Docetaxel; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Receptor, ErbB-2; Survival Analysis; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A; Vomiting	2005
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer. American journal of clinical oncology, 2005, Volume: 28, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Carboplatin; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Stomach Neoplasms; Taxoids	2005
Phase I study of vinorelbine plus gemcitabine as third-line chemotherapy for refractory non-small cell lung cancer. Oncology reports, 2005, Volume: 14, Issue:3 Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2005
Docetaxel and cisplatin combination chemotherapy in metastatic breast cancer patients with previous exposure to anthracyclines. Breast (Edinburgh, Scotland), 2005, Volume: 14, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Disease Progression; Docetaxel; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2005
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-15, Volume: 11, Issue:16 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Taxoids; Treatment Outcome; Vomiting	2005
Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Darbepoetin alfa; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Erythropoietin; Female; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Ki-67 Antigen; Middle Aged; Neutropenia; Polyethylene Glycols; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Recombinant Proteins; Taxoids; Treatment Outcome	2005
[Phase II study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Taxoids	2005
A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer. Investigational new drugs, 2006, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Treatment Outcome	2006
[Evaluation of a combination chemotherapy with docetaxel and nedaplatin for patients with oral squamous cell carcinomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Taxoids	2005
A phase II study of docetaxel and cisplatin in patients with gastric cancer recurring after or progressing during 5-FU/platinum treatment. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:12 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Gastrectomy; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2005
Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients? Cancer treatment reviews, 2005, Volume: 31 Suppl 4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Prodrugs; Prospective Studies; Remission Induction; Taxoids	2005
Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial. Clinical breast cancer, 2005, Volume: 6, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids	2005
Epirubicin-docetaxel in advanced gastric cancer: two phase II studies as second and first line treatment. Bulletin du cancer, 2006, Volume: 93, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. International journal of cancer, 2006, Aug-01, Volume: 119, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Middle Aged; Nausea; Neutropenia; Retrospective Studies; Sarcoma; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome	2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:6 Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome	2006
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Half-Life; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Taxoids; Treatment Outcome	2006
Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Esophagitis; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome	2006
Phase I study of docetaxel and topotecan in patients with advanced malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2005, Volume: 11, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Cells; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Taxoids; Thrombocytopenia; Topotecan; Treatment Outcome	2005
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers. Investigational new drugs, 2006, Volume: 24, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Oligonucleotides; Pancreatic Neoplasms; Prothrombin Time; Taxoids	2006
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Disease Progression; Docetaxel; Female; Humans; Male; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Palliative Care; Stomach Neoplasms; Taxoids; Vomiting	2007
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony sti Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Middle Aged; Neutropenia; Quality of Life; Taxoids	2006
A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jul-15, Volume: 12, Issue:14 Pt 1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Chemical; Morpholines; Neoplasms; Neutropenia; Taxoids	2006
[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Remission Induction; Survival Rate; Taxoids; Vomiting	2006
[Combination chemotherapy of S-1 and docetaxel on advanced and recurrent gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 1 Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2006
Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Taxoids; Treatment Outcome; Vomiting	2007
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-01, Volume: 24, Issue:34 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Prospective Studies; Survival Rate; Taxoids; Vomiting	2006
Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Taxoids	2007
[Docetaxel in the treatment of advanced breast cancer ]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Neoplasm Staging; Neutropenia; Remission Induction; Taxoids; Treatment Outcome; Vomiting	2006
A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer. Oncology, 2006, Volume: 70, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fever; Follow-Up Studies; Humans; Kidney; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting	2006
[Phase I/II clinical trial of induction chemotherapy with nedaplatin (CDGP), docetaxel (DOC) and 5-fluorouracil (5-FU) for squamous cell carcinoma of head and neck]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Quality of Life; Taxoids	2007
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation-Sensitizing Agents; Survival Rate; Taxoids; Treatment Outcome	2007
[The safety of docetaxel with cyclophosphamide (TC) therapy as adjuvant chemotherapy for Japanese women with operable breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Humans; Leukopenia; Lymphatic Metastasis; Middle Aged; Neutropenia; Taxoids; Treatment Outcome	2007
Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer. Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Estramustine; Floxuridine; Granulocyte Colony-Stimulating Factor; Humans; Japan; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Survival Rate; Taxoids	2008
A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linear Models; Lung Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Staging; Neutropenia; Probability; Proportional Hazards Models; Risk Factors; Survival Analysis; Taxoids; Treatment Outcome	2007
[Phase I study of docetaxel combined with carboplatin in patients with non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Taxoids	2006
A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer. Investigational new drugs, 2007, Volume: 25, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Disease Progression; Docetaxel; Female; Gefitinib; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Quinazolines; Taxoids; Treatment Outcome	2007
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma. British journal of cancer, 2007, Sep-03, Volume: 97, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Diarrhea; Disease Progression; Docetaxel; Esophagogastric Junction; Female; Fever; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Mucositis; Neoplasm Metastasis; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome; Vomiting	2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Diseases; Child; Child, Preschool; Docetaxel; Drug Administration Schedule; Female; Fever; Humans; Infant; Infusions, Intravenous; Leukemia; Leukemia, Myeloid; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Taxoids; Treatment Failure	2008
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study. Investigational new drugs, 2008, Volume: 26, Issue:1 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diarrhea; Docetaxel; Female; Gemcitabine; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Taxoids; Time Factors; Treatment Outcome; Vinblastine; Vinorelbine	2008
A single-institute phase I/II trial combining nedaplatin dose escalation with a fixed dose of docetaxel for induction chemotherapy of oral squamous cell carcinoma. Oral oncology, 2008, Volume: 44, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Neutropenia; Organoplatinum Compounds; Remission Induction; Taxoids	2008
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial. Oncology, 2006, Volume: 71, Issue:5-6 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neutropenia; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Thrombocytopenia; Treatment Outcome	2006
PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. The pharmacogenomics journal, 2008, Volume: 8, Issue:2 Topics: 5' Untranslated Regions; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asian People; Blood Platelets; Breast Neoplasms; China; Constitutive Androstane Receptor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Doxorubicin; Exons; Female; Gene Expression Regulation, Neoplastic; Gene Frequency; Genotype; Hepatocyte Nuclear Factor 4; Humans; India; Malaysia; Middle Aged; Neutropenia; Polymorphism, Genetic; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Singapore; Taxoids; Time Factors; Transcription Factors; Treatment Outcome	2008
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Dexamethasone; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Female; Gastrointestinal Diseases; Humans; Magnesium Sulfate; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Premedication; Stomach Neoplasms; Taxoids; Treatment Outcome	2008
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:2 Topics: Antineoplastic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Docetaxel; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Ketoconazole; Male; Maximum Tolerated Dose; Midazolam; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neutropenia; Taxoids	2008
Toxicity of dose-dense docetaxel followed by doxorubicin with cyclophosphamide as adjuvant therapy for breast cancer in a phase II study. Clinical breast cancer, 2007, Volume: 7, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Female; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Neutropenia; Paresthesia; Taxoids	2007
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Diarrhea; Disease Progression; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; Docetaxel; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Genotype; Glucuronosyltransferase; Humans; Irinotecan; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Polymorphism, Single Nucleotide; Stomach Neoplasms; Survival Analysis; Taxoids; Xeroderma Pigmentosum Group D Protein	2008
Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan. Japanese journal of clinical oncology, 2008, Volume: 38, Issue:5 Topics: Aged; Alopecia; Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Feasibility Studies; Humans; Japan; Leukopenia; Male; Middle Aged; Neutropenia; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome	2008
Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Stud Anti-cancer drugs, 2008, Volume: 19, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Erythropoietin; Esophageal Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Rate; Taxoids	2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study. British journal of cancer, 2008, May-06, Volume: 98, Issue:9 Topics: Adult; Aged; Alopecia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Belgium; Boronic Acids; Bortezomib; Breast Neoplasms; Breast Neoplasms, Male; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Neutropenia; Prospective Studies; Pyrazines; Spain; Taxoids; Treatment Outcome; United Kingdom; Vomiting	2008
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer. Cancer, 1995, Feb-15, Volume: 75, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Prednisone; Premedication; Survival Rate; Taxoids	1995
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Hypersensitivity; Drug Resistance; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Remission Induction; Survival Rate; Taxoids	1995
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12 Topics: Adolescent; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Paclitaxel; Taxoids	1994
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Europe; Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:6 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Asthenia; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Europe; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1994
[An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids	1994
[Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Uterine Cervical Neoplasms	1994
Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Carboplatin; Cisplatin; Docetaxel; Drug Resistance; Female; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Analysis; Taxoids	1994
A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer. British journal of cancer, 1996, Volume: 73, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Carcinoma, Medullary; Carcinoma, Papillary; Docetaxel; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Toxicity Tests	1996
Docetaxel (Taxotere): an overview of first-line monotherapy. Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 13 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	1995
[Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]. Bulletin du cancer, 1996, Volume: 83, Issue:1 Topics: Antidiarrheals; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Humans; Irinotecan; Loperamide; Male; Neoplasms; Neutropenia; Paclitaxel; Remission Induction; Taxoids; Topoisomerase I Inhibitors	1996
Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy. Medical oncology (Northwood, London, England), 1996, Volume: 13, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neutropenia; Paclitaxel; Taxoids	1996
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Docetaxel; Drug Administration Schedule; Female; Humans; Incidence; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Paclitaxel; Severity of Illness Index; Taxoids; Treatment Outcome	1997
Docetaxel in combination with doxorubicin: a phase I dose-finding study. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:6 Suppl 6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Neoplasm Metastasis; Neutropenia; Paclitaxel; Pilot Projects; Survival Rate; Taxoids	1997
Docetaxel and cyclophosphamide in patients with advanced solid tumors. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:6 Suppl 6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Humans; Neoplasms; Neutropenia; Paclitaxel; Taxoids	1997
Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:6 Suppl 6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Pilot Projects; Taxoids	1997
Docetaxel combined with vinorelbine: phase I results and new study designs. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:6 Suppl 6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Liver Neoplasms; Neoplasm Metastasis; Neutropenia; Paclitaxel; Research Design; Taxoids; Vinblastine; Vinorelbine	1997
Docetaxel in combination with fluorouracil: study design and preliminary results. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:6 Suppl 6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Paclitaxel; Taxoids	1997
Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Doxorubicin; Drug Administration Schedule; Estrogen Antagonists; Female; Fever; Humans; Infusions, Intravenous; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Remission Induction; Tamoxifen; Taxoids	1997
Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bacterial Infections; Breast Neoplasms; Cause of Death; Disease Progression; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Female; Fever; Heart Diseases; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Quality of Life; Remission Induction; Safety; Survival Rate; Taxoids; Thrombocytopenia	1997
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclophosphamide; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Premedication; Remission Induction; Sarcoma; Taxoids	1997
Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fever; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1997
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Bayes Theorem; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Docetaxel; Edema; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Prospective Studies; Taxoids	1998
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours. British journal of cancer, 1998, Volume: 77, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Paclitaxel; Taxoids; Vomiting	1998
Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33 Suppl 7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Recombinant Proteins; Taxoids	1997
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Edema; Female; Fever; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Taxoids	1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients. British journal of cancer, 1998, Volume: 78, Issue:10 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Disease Progression; Docetaxel; Drug Administration Schedule; Edema; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome; Urologic Neoplasms	1998
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine. Cancer, 1998, Nov-15, Volume: 83, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Patient Compliance; Recombinant Proteins; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	1998
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1999
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. International journal of radiation oncology, biology, physics, 1999, Jan-01, Volume: 43, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Glioblastoma; Humans; Lung Neoplasms; Lymphocytes; Lymphopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pelvic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy; Survival Analysis; Taxoids; Treatment Outcome	1999
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:13 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome	1998
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lymphocyte Count; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Paclitaxel; Remission Induction; Taxoids; Ventricular Function, Left	1999
Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:4 Topics: Adolescent; Adult; Child; Child, Preschool; Docetaxel; Dose-Response Relationship, Drug; Drug Eruptions; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infant; Male; Neoplasms; Neutropenia; Paclitaxel; Recombinant Proteins; Taxoids	1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:5 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Health Status; Humans; Middle Aged; Mitomycins; Neutropenia; Paclitaxel; Patient Compliance; Proportional Hazards Models; Prospective Studies; Survival Analysis; Taxoids; Thrombocytopenia; Vinblastine	1999
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors. Cancer, 2000, Jan-01, Volume: 88, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome	2000
Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:12 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Neutropenia; Paclitaxel; Taxoids	1999
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:3 Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Breast Neoplasms, Male; Chemical and Drug Induced Liver Injury; Docetaxel; Drug Resistance, Neoplasm; Female; Fever; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Paclitaxel; Prognosis; Risk Factors; Stomatitis; Taxoids; Treatment Outcome	2000
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Taxoids	2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:3 Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Alopecia; Antineoplastic Agents, Phytogenic; Area Under Curve; Aspartate Aminotransferases; Breast Neoplasms; Diarrhea; Docetaxel; Fatigue; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mouth Mucosa; Neoplasms; Neutropenia; Paclitaxel; Stomatitis; Taxoids; Time Factors	2000
Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer. Japanese journal of clinical oncology, 1999, Volume: 29, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neutropenia; Paclitaxel; Taxoids	1999
Intestinal side-effects of docetaxel/vinorelbine combination. Lancet (London, England), 2000, Mar-25, Volume: 355, Issue:9209 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastroenteritis; Humans; Neutropenia; Paclitaxel; Risk Factors; Taxoids; Vinblastine; Vinorelbine	2000
[Efficacy of docetaxel in non-small cell lung cancer patients previously treated with platinum-containing chemotherapy. French Group of Pneumo-Cancerology]. Revue des maladies respiratoires, 2000, Volume: 17, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diosmin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Prednisolone; Premedication; Taxoids; Time Factors	2000
Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: a phase II feasibility study. American journal of clinical oncology, 2000, Volume: 23, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Recurrence; Taxoids	2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study. American journal of clinical oncology, 2000, Volume: 23, Issue:2 Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cohort Studies; Dexamethasone; Docetaxel; Drug Resistance, Neoplasm; Female; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Paclitaxel; Prednisone; Taxoids	2000
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Docetaxel; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Male; Middle Aged; Mouth Mucosa; Neoplasms; Neutropenia; Paclitaxel; Quinolines; Stomatitis; Taxoids; Vomiting	2000
A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2000
Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer. Acta oncologica (Stockholm, Sweden), 2000, Volume: 39, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Docetaxel; Female; Fever; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome; Water-Electrolyte Balance	2000
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours. British journal of cancer, 2000, Volume: 83, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Biotransformation; Capecitabine; Carboxylic Ester Hydrolases; Deamination; Deoxycytidine; Dexamethasone; Docetaxel; Drug Administration Schedule; Female; Fever; Fluorouracil; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Liver; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Paronychia; Prodrugs; Remission Induction; Taxoids; Treatment Outcome	2000
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study. Anti-cancer drugs, 2000, Volume: 11, Issue:4 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Feasibility Studies; Female; Humans; Irinotecan; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Pleural Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2000
Phase I and pharmacologic study of docetaxel and irinotecan in advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Camptothecin; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Disease-Free Survival; Docetaxel; Female; Humans; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Microtubules; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome	2000
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial. American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Confidence Intervals; Disease Progression; Docetaxel; Female; Fever; Follow-Up Studies; Gastrectomy; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2000
Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Survival Analysis; Taxoids	2000
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2000
Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:10 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Chromatography, High Pressure Liquid; Cross-Over Studies; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Time Factors	2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study. Bone marrow transplantation, 2000, Volume: 26, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diarrhea; Disease Progression; Docetaxel; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Interstitial; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Recombinant Proteins; Remission Induction; Stomatitis; Survival Analysis; Taxoids; Thiotepa; Thrombocytopenia; Transplantation Conditioning	2000
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy. Lung cancer (Amsterdam, Netherlands), 2000, Volume: 30, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fever; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Salvage Therapy; Taxoids	2000
A dose escalation study of weekly docetaxel in patients with advanced solid tumors. Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Taxoids	2000
Docetaxel in patients with anthracycline-resistant advanced breast cancer. Oncology, 2001, Volume: 60, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome	2001
A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: a Japanese cooperative study. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Treatment Outcome	2000
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. British journal of cancer, 2001, Volume: 84, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Fatigue; Female; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leucovorin; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome	2001
Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Docetaxel; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2001
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Recombinant Proteins; Salvage Therapy; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome	2001
A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer. Bone marrow transplantation, 2001, Volume: 27, Issue:7 Topics: Adult; Antigens, CD34; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Leukocyte Count; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Stem Cells; Taxoids	2001
A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:3 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2001
Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-15, Volume: 19, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Heart; Humans; Infusions, Intravenous; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Survival Rate; Taxoids	2001
A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 33, Issue:1 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fever; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia	2001
[Evaluation of efficacy and toxicity of docetaxel (Taxotere) in patients with advanced mammary gland cancer]. Przeglad lekarski, 2001, Volume: 58, Issue:2 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Survival Rate; Taxoids; Treatment Outcome	2001
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:6 Topics: Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Mitoxantrone; Nausea; Neutropenia; Paclitaxel; Sepsis; Survival Rate; Taxoids	2001
[Effect of weekly docetaxel in patients with recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pilot Projects; Taxoids	2001
Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	2001
Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2001
Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome	2001
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. Cancer, 2001, Nov-01, Volume: 92, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Fever; Gemcitabine; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2001
Weekly docetaxel (Taxotere) in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2001
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neutropenia; Paclitaxel; Skin Neoplasms; Taxoids; Temozolomide; Thrombocytopenia	2002
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dermatitis; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia	2001
Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 35, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome	2002
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Recombinant Proteins; Taxoids	2002
Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial. British journal of cancer, 2002, Mar-04, Volume: 86, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2002
Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Mar-15, Volume: 20, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome	2002
Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase II study. Cancer, 2002, Feb-15, Volume: 94, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2002
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2002
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jun-15, Volume: 20, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leiomyosarcoma; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome; Uterine Neoplasms	2002

Other Studies

157 other study(ies) available for docetaxel anhydrous and Neutropenia

Article	Year
Results of the observational prospective RealFLOT study. BMC cancer, 2021, Oct-08, Volume: 21, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Feasibility Studies; Female; Fluorouracil; Humans; Italy; Male; Microsatellite Instability; Middle Aged; Neutropenia; Oxaliplatin; Prognosis; Prospective Studies; Stomach Neoplasms	2021
Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma. Anticancer research, 2021, Volume: 41, Issue:11 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Immune Checkpoint Inhibitors; Male; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2021
Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer. Investigational new drugs, 2022, Volume: 40, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Neutropenia; Polymorphism, Genetic; Retrospective Studies	2022
Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study. Anticancer research, 2022, Volume: 42, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Filgrastim; Fluorouracil; Humans; Lymphoma, Follicular; Neutropenia; Polyethylene Glycols; Retrospective Studies	2022
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer. The Prostate, 2022, Volume: 82, Issue:14 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Male; Neutropenia; Orchiectomy; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Risk Factors; Treatment Outcome	2022
Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis. European journal of medical research, 2022, Aug-11, Volume: 27, Issue:1 Topics: Androgen Antagonists; Androgens; Antineoplastic Combined Chemotherapy Protocols; China; Docetaxel; Humans; Male; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Treatment Outcome	2022
Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients. Acta medica Indonesiana, 2022, Volume: 54, Issue:3 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols	2022
Influence of using history of immune checkpoint inhibitor therapy for neutropenia caused by combination therapy of ramucirumab and docetaxel. Die Pharmazie, 2022, 09-01, Volume: 77, Issue:7 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Neutropenia; Ramucirumab; Retrospective Studies	2022
NOAEL cancer therapy: a tumor targetable docetaxel-inorganic polymer nanohybrid prevents drug-induced neutropenia. Journal of materials chemistry. B, 2023, 01-18, Volume: 11, Issue:3 Topics: Docetaxel; Humans; Neutropenia; No-Observed-Adverse-Effect Level; Pancreatic Neoplasms; Polymers; Taxoids	2023
Optimal exposure to docetaxel in adjuvant chemotherapy for early-stage breast cancer. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Female; Hemoglobins; Humans; Neutropenia; Platinum; Taxoids	2022
Docetaxel+Cisplatin+5-FU (DCF) Therapy as a Preoperative Chemotherapy to Advanced Esophageal Squamous Cell Carcinoma: A Single-center Retrospective Cohort Study. Internal medicine (Tokyo, Japan), 2023, Volume: 62, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Neutropenia; Retrospective Studies; Taxoids; Treatment Outcome	2023
Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data. PloS one, 2023, Volume: 18, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Interactions; Female; Granulocyte Colony-Stimulating Factor; Humans; Insurance; Neutropenia; Taxoids	2023
Primary G-CSF prophylaxis following docetaxel treatment. The Netherlands journal of medicine, 2019, Volume: 77, Issue:9 Topics: Docetaxel; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia	2019
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. Cancer chemotherapy and pharmacology, 2020, Volume: 86, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Biomarkers, Tumor; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neutropenia; Polymorphism, Genetic; Prognosis; Retrospective Studies; Risk Factors; Survival Rate	2020
Eflapegrastim's enhancement of efficacy compared with pegfilgrastim in neutropenic rats supports potential for same-day dosing. Experimental hematology, 2020, Volume: 92 Topics: Animals; Cyclophosphamide; Docetaxel; Filgrastim; Histocompatibility Antigens Class I; Humans; Male; Mice; Neutropenia; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Fc; U937 Cells	2020
Dose individualisation in oncology using chemotherapy-induced neutropenia: Example of docetaxel in non-small cell lung cancer patients. British journal of clinical pharmacology, 2021, Volume: 87, Issue:4 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lung Neoplasms; Neutropenia; Taxoids	2021
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma. Japanese journal of clinical oncology, 2021, Feb-08, Volume: 51, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils	2021
Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen. Chemotherapy, 2017, Volume: 62, Issue:4 Topics: Aged; Alanine Transaminase; Antineoplastic Agents; Area Under Curve; Blood Platelets; Cisplatin; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Platelet Count; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; ROC Curve; Taxoids	2017
Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis. PloS one, 2017, Volume: 12, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Neoplasms; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Gemcitabine; Humans; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult	2017
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. Journal of gynecologic oncology, 2017, Volume: 28, Issue:4 Topics: Adult; Aged; Albumins; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Retreatment; Retrospective Studies; Taxoids; Thrombocytopenia	2017
Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer. Anticancer research, 2017, Volume: 37, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Sarcopenia; Taxoids	2017
Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring. Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:2 Topics: Antineoplastic Agents; Computer Simulation; Docetaxel; Drug Monitoring; Humans; Leukocyte Count; Models, Biological; Neoplasms; Neutropenia; Neutrophils; Taxoids; Time Factors	2017
Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area. Cancer research and treatment, 2018, Volume: 50, Issue:3 Topics: Adult; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Prognosis; Survival Analysis; Taxoids; Young Adult	2018
Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer. Scientific reports, 2017, 09-07, Volume: 7, Issue:1 Topics: Aged; Albumins; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Treatment Outcome	2017
Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer. Cancer letters, 2017, 12-01, Volume: 410 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carboxymethylcellulose Sodium; Cell Line, Tumor; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Compounding; Drug Liberation; Drug Resistance, Neoplasm; Humans; Male; Maximum Tolerated Dose; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Neutropenia; Particle Size; Prostatic Neoplasms, Castration-Resistant; Solubility; Taxoids; Tissue Distribution; Xenograft Model Antitumor Assays	2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study. Lung cancer (Amsterdam, Netherlands), 2017, Volume: 113 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam	2017
Toxicity of docetaxel, carboplatin, and trastuzumab combination as adjuvant or neo-adjuvant treatment for Her2 positive breast cancer patients and impact of colony-stimulating factor prophylaxis. The breast journal, 2018, Volume: 24, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Colony-Stimulating Factors; Disease-Free Survival; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Receptor, ErbB-2; Trastuzumab	2018
[Effect of Pegfilgrastim Primary Prophylactic Administration on Relative Dose Intensity(RDI)in Postoperative Adjuvant Chemotherapy(TC Therapy)for Breast Cancer - A Single-Center, Retrospective Study]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Filgrastim; Humans; Middle Aged; Neutropenia; Polyethylene Glycols; Retrospective Studies; Taxoids	2017
Enterocolitis in Patients with Cancer Treated with Docetaxel. Anticancer research, 2018, Volume: 38, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Enterocolitis; Female; Humans; Incidence; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Retrospective Studies; Taxoids; Vomiting; Young Adult	2018
[Neoadjuvant chemotherapy with concurrent chemoradiotherapy in the treatment of nasopharyngeal cancer: Southern Tunisian experience]. Bulletin du cancer, 2018, Volume: 105, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Radiotherapy Dosage; Retrospective Studies; Taxoids; Tunisia	2018
Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone-naïve prostate cancer: The first real-life experience in Asia. Asia-Pacific journal of clinical oncology, 2018, Volume: 14, Issue:4 Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Granulocyte Colony-Stimulating Factor; Hong Kong; Humans; Kallikreins; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant	2018
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel. Clinical genitourinary cancer, 2018, Volume: 16, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Blood Cell Count; Docetaxel; Humans; Male; Middle Aged; Neutropenia; Patient Outcome Assessment; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Analysis; Treatment Outcome	2018
Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer. Esophagus : official journal of the Japan Esophageal Society, 2018, Volume: 15, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Retrospective Studies; Survival Rate	2018
Efficacy and Safety of Bi-weekly Pegfilgrastim for Dose-dense Chemotherapy-induced Neutropenia in Breast Cancer Patients. Anticancer research, 2018, Volume: 38, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Polyethylene Glycols; Taxoids	2018
Efficacy of pegfilgrastim administration in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil. Die Pharmazie, 2018, 10-01, Volume: 73, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Filgrastim; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Retrospective Studies	2018
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma. BMC cancer, 2018, Dec-20, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Cell Line, Tumor; Cisplatin; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Herpesvirus 4, Human; Humans; Liposomes; Male; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids	2018
[Impact of Primary Prophylaxis with Pegfilgrastim on Clinical Outcomes in Patients with Advanced Esophageal Cancer Receiving Chemotherapy with Docetaxel, Cisplatin ,and 5-FU]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Filgrastim; Fluorouracil; Humans; Neutropenia; Polyethylene Glycols; Prospective Studies; Retrospective Studies; Taxoids	2018
Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort. BMC cancer, 2019, Mar-19, Volume: 19, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neutropenia; Polymorphism, Single Nucleotide	2019
Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia. European journal of cancer care, 2019, Volume: 28, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Emergencies; Female; Fever; Hospitalization; Humans; Infections; Kaplan-Meier Estimate; Logistic Models; Mastectomy; Mastectomy, Segmental; Middle Aged; Neutropenia; New South Wales; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate; Trastuzumab	2019
Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinoma. American journal of clinical oncology, 2015, Volume: 38, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Feasibility Studies; Female; Fluorouracil; Gastrectomy; Heart Arrest; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Sepsis; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diarrhea; Docetaxel; Drug Eruptions; Epirubicin; Feasibility Studies; Female; Humans; Middle Aged; Myalgia; Neutropenia; Pilot Projects; Taxoids	2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer. Cancer, 2013, Sep-01, Volume: 119, Issue:17 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Hemoglobins; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Orchiectomy; Organometallic Compounds; Organophosphorus Compounds; Platelet Count; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Severity of Illness Index; Taxoids; Thrombocytopenia; Treatment Outcome	2013
Toxicity of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for advanced head and neck cancer. The Israel Medical Association journal : IMAJ, 2013, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Feasibility Studies; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Taxoids	2013
Predictive factors for neutropenia after docetaxel-based systemic chemotherapy in Korean patients with castration- resistant prostate cancer. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:8 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Creatinine; Docetaxel; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Neutropenia; Neutrophils; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Risk Factors; Serum Albumin; Taxoids	2014
Retrospective analysis of severe neutropenia in patients receiving concomitant administration of docetaxel and clarithromycin. Chemotherapy, 2013, Volume: 59, Issue:6 Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Odds Ratio; Retrospective Studies; Severity of Illness Index; Sex Factors; Taxoids	2013
Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:3 Topics: Age Factors; Aged; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Humans; Male; Middle Aged; Neutropenia; Prostatic Neoplasms, Castration-Resistant; Radiotherapy; Risk Factors; Taxoids	2015
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Platinum; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome	2014
[Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:7 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Gemcitabine; Humans; Leiomyosarcoma; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Sarcoma; Taxoids; Treatment Outcome	2014
Dose schedule optimization and the pharmacokinetic driver of neutropenia. PloS one, 2014, Volume: 9, Issue:10 Topics: Animals; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Male; Models, Biological; Models, Theoretical; Neutropenia; Rats, Sprague-Dawley; Taxoids; Topotecan	2014
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Science translational medicine, 2015, Mar-18, Volume: 7, Issue:279 Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; bcl-X Protein; Benzothiazoles; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Docetaxel; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Granulocytes; Humans; Isoquinolines; Kinetics; Mice; Neoplasm Transplantation; Neoplasms; Neutropenia; Neutrophils; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Taxoids; Thrombocytopenia	2015
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer. American journal of clinical oncology, 2017, Volume: 40, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia	2017
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics. The pharmacogenomics journal, 2016, Volume: 16, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Databases, Genetic; Docetaxel; Female; Genetic Predisposition to Disease; Humans; Inactivation, Metabolic; Male; Membrane Transport Proteins; Metabolic Clearance Rate; Middle Aged; Models, Genetic; Neutropenia; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Severity of Illness Index; Taxoids; Young Adult	2016
[Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Liposomes; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Remission Induction; Taxoids	2015
[Clinical Investigation of the Effects of Filgrastim BS1 on Neutropenia Following Oral Cancer Chemotherapy (TPF Therapy)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Recombinant Proteins; Taxoids; Treatment Outcome	2015
Docetaxel-based adjuvant therapy for breast cancer patients in Asia-Pacific region: Results from 5 years follow-up on Asia-Pacific Breast Initiative-I. Asia-Pacific journal of clinical oncology, 2016, Volume: 12, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asia; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Docetaxel; Female; Follow-Up Studies; Humans; Longitudinal Studies; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Taxoids	2016
Planned Esophagectomy after Neoadjuvant Hyperthermo-Chemoradiotherapy using Weekly Low-Dose Docetaxel and Hyperthermia for Advanced Esophageal Carcinomas. Hepato-gastroenterology, 2015, Volume: 62, Issue:140 Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagitis; Female; Humans; Hyperthermia, Induced; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Prospective Studies; Survival Rate; Taxoids; Treatment Outcome	2015
High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice. Clinical oncology (Royal College of Radiologists (Great Britain)), 2016, Volume: 28, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Male; Neutropenia; Prostatic Neoplasms; Taxoids	2016
Upfront Chemohormonal Therapy for Prostate Cancer: Neutropenia and G-CSF Use. Acta bio-medica : Atenei Parmensis, 2016, 05-06, Volume: 87, Issue:1 Topics: Aged; Androgen Antagonists; Docetaxel; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Prostatic Neoplasms; Taxoids	2016
Development of a Nomogram for Predicting Severe Neutropenia Associated With Docetaxel-Based Chemotherapy in Patients With Castration-Resistant Prostate Cancer. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Humans; Incidence; Kallikreins; Logistic Models; Male; Middle Aged; Neutropenia; Nomograms; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Risk Factors; Taxoids	2017
Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fever; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Liver; Male; Middle Aged; Neutropenia; Risk Factors; Taxoids; Ultrasonography	2016
Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. Clinical oncology (Royal College of Radiologists (Great Britain)), 2016, Volume: 28, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Male; Neutropenia; Prostatic Neoplasms; Taxoids	2016
Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 11-10, Volume: 34, Issue:32 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Databases, Factual; Docetaxel; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Insurance, Health; Middle Aged; Neutropenia; Retrospective Studies; Taxoids; Trastuzumab; Young Adult	2016
Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients. World journal of surgical oncology, 2016, Dec-08, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Disease-Free Survival; Docetaxel; Feasibility Studies; Gemcitabine; Humans; Japan; Middle Aged; Neutropenia; Osteosarcoma; Pneumonia; Retrospective Studies; Sarcoma; Taxoids; Treatment Outcome; Tubulin Modulators; Young Adult	2016
Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy. Anticancer research, 2017, Volume: 37, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deglutition Disorders; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mucositis; Multivariate Analysis; Neoplasm Staging; Neoplasms, Second Primary; Neutropenia; Radiotherapy Dosage; Retrospective Studies; Taxoids; Treatment Outcome	2017
Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma. AIDS (London, England), 2008, Jun-19, Volume: 22, Issue:10 Topics: Adult; Antineoplastic Agents; Contraindications; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Drug Interactions; Drug Therapy, Combination; Eyelid Neoplasms; HIV Infections; HIV Protease Inhibitors; Humans; Male; Neutropenia; Ritonavir; Sarcoma, Kaposi; Taxoids	2008
Treatment for lung metastasis from head and neck squamous cell carcinoma: a preliminary study of docetaxel. Oral and maxillofacial surgery, 2008, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Tolerance; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Prognosis; Retrospective Studies; Taxoids	2008
Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Aug-15, Volume: 65, Issue:16 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Middle Aged; Neutropenia; Recombinant Proteins; Retrospective Studies; Taxoids	2008
[Efficacy and toxicity of trastuzumab combined with docetaxel for Her-2/neu overexpressing metastatic breast cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2008, Volume: 27, Issue:9 Topics: Adult; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Exanthema; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Neutropenia; Receptor, ErbB-2; Remission Induction; Survival Rate; Taxoids; Thrombocytopenia; Trastuzumab	2008
An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics. Journal of pharmacokinetics and pharmacodynamics, 2008, Volume: 35, Issue:6 Topics: Antineoplastic Agents; Cisplatin; Computer Simulation; Docetaxel; Dose-Response Relationship, Drug; Drug Dosage Calculations; Humans; Models, Biological; Neutropenia; Taxoids	2008
The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Administration Schedule; Female; Filgrastim; Genital Neoplasms, Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Taxoids; Young Adult	2009
Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Gastrectomy; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide. European journal of cancer care, 2010, Volume: 19, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids; Treatment Outcome	2010
The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Fever; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neutropenia; Retrospective Studies; Stomach Neoplasms; Taxoids; Young Adult	2010
High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-10, Volume: 27, Issue:26 Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Fever; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia; Taxoids	2009
[Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin]. Medicina (Kaunas, Lithuania), 2009, Volume: 45, Issue:8 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Informed Consent; Middle Aged; Neutropenia; Quality of Life; Recombinant Proteins; Taxoids; Time Factors	2009
[Proposal of a novel dosing schedule of docetaxel by using alpha1-acid glycoprotein as an index]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:12 Topics: Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Humans; Models, Biological; Monte Carlo Method; Neutropenia; Orosomucoid; Reference Standards; Taxoids	2009
Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:3 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome	2010
Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients. British journal of clinical pharmacology, 2010, Volume: 69, Issue:1 Topics: Adult; Antineoplastic Agents; Docetaxel; Drug Interactions; Exanthema; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Mucositis; Neutropenia; Ritonavir; Seizures, Febrile; Taxoids	2010
Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diarrhea; Docetaxel; Greece; Humans; Kaplan-Meier Estimate; Neutropenia; Stomach Neoplasms; Taxoids; Treatment Outcome	2010
Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Docetaxel; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Taxoids; Treatment Outcome	2011
Prognostic significance of neutropenia on day one of anthracycline-based neoadjuvant chemotherapy in operable breast cancer. Oncology, 2010, Volume: 78, Issue:3-4 Topics: Adult; Aged; Anthracyclines; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neutropenia; Prognosis; Taxoids; Treatment Outcome	2010
New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials, Phase II as Topic; Denmark; Deoxycytidine; Diarrhea; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Fever; Fluorouracil; Humans; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2011
[Analysis of four patients with advanced gastric cancer undergoing gastrectomy after pre-operative combination chemotherapy using docetaxel, cisplatin and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Neutropenia; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fever; Humans; Maximum Tolerated Dose; Medical Audit; Middle Aged; Neutropenia; Retrospective Studies; Taxoids; Treatment Outcome	2011
[Comparison of the efficacy of nedaplatin combined with docetaxel and docetaxel alone as a second line treatment for advanced non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Taxoids; Vomiting	2010
[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2010, Volume: 29, Issue:174 Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Neutropenia; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Vomiting	2010
[Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cerebral Infarction; Docetaxel; Drug Combinations; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Oxonic Acid; Taxoids; Tegafur	2011
Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients. Clinical lung cancer, 2011, Volume: 12, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Polymorphism, Genetic; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome; Xeroderma Pigmentosum Group D Protein	2011
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pancreatic Neoplasms; Retrospective Studies; Taxoids; Treatment Outcome	2012
[Administration of dicarbamin in the course of taxotere-assisted chemotherapy]. Voprosy onkologii, 2011, Volume: 57, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caproates; Docetaxel; Drug Administration Schedule; Female; Humans; Imidazoles; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Ovarian Neoplasms; Prostatic Neoplasms; Protective Agents; Taxoids; Treatment Outcome	2011
Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Taxoids	2012
TAXTOX - a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Denmark; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Retrospective Studies; Taxoids	2011
[Efficacy and safety of gefitinib or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed previous platinum-based first-line chemotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:5 Topics: Adult; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Diarrhea; Disease-Free Survival; Docetaxel; Exanthema; Female; Gefitinib; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neutropenia; Platinum; Quality of Life; Quinazolines; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Survival Rate; Taxoids	2011
Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer. Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Monitoring; Fever; Fluorouracil; Head and Neck Neoplasms; Humans; Incidence; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neutropenia; Severity of Illness Index; Survival Analysis; Taiwan; Taxoids	2012
Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:7 Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fever; Humans; Leukocyte Count; Middle Aged; Models, Biological; Neutropenia; Neutrophils; Retrospective Studies; Risk Assessment; Taxoids	2012
The shape of the myelosuppression time profile is related to the probability of developing neutropenic fever in patients with docetaxel-induced grade IV neutropenia. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Female; Fever; Humans; Middle Aged; Models, Biological; Neutropenia; Risk Factors; Taxoids	2012
[Use of Taxotere in adjuvant chemotherapy of breast cancer]. Voprosy onkologii, 2011, Volume: 57, Issue:5 Topics: Anemia, Hypochromic; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Erythrocyte Transfusion; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia; Taxoids; Treatment Outcome	2011
Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. Chemotherapy, 2012, Volume: 58, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cohort Studies; Costs and Cost Analysis; Cyclophosphamide; Databases, Factual; Docetaxel; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Health Care Costs; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Retrospective Studies; Risk Factors; Taxoids	2012
[Support of hematological homeostasis during chemotherapy with taxanes]. Voprosy onkologii, 2011, Volume: 57, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caproates; Docetaxel; Female; Fever; Follow-Up Studies; Homeostasis; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Protective Agents; Severity of Illness Index; Stomach Neoplasms; Taxoids; Tongue Neoplasms	2011
An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Docetaxel; Female; Genital Neoplasms, Female; Genotype; Humans; Middle Aged; Neutropenia; Polymorphism, Single Nucleotide; Steroid Hydroxylases; Taxoids	2012
Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model. British journal of cancer, 2012, Aug-21, Volume: 107, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Computer Simulation; Docetaxel; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Reproducibility of Results; Taxoids	2012
Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Turkey	2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme. European urology, 2013, Volume: 63, Issue:6 Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Compassionate Use Trials; Disease-Free Survival; Docetaxel; Fever; Germany; Humans; Kallikreins; Male; Middle Aged; Neutropenia; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Thrombocytopenia; Treatment Failure; Treatment Outcome	2013
Risk of treatment related death and febrile neutropaenia with taxane-based adjuvant chemotherapy for breast cancer in a middle income country outside a clinical trial setting. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Carboplatin; Cause of Death; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Female; Fever; Fluorouracil; Humans; Malaysia; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Risk Factors; Taxoids	2012
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenetics and genomics, 2013, Volume: 23, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Docetaxel; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasms; Neutropenia; Organic Anion Transporters, Sodium-Independent; Pharmacogenetics; Polymorphism, Single Nucleotide; Retrospective Studies; Solute Carrier Organic Anion Transporter Family Member 1B3; Taxoids; Tissue Distribution	2013
Pegfilgrastim: the promise of pegylation fulfilled. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Taxoids	2003
Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel. International journal of clinical oncology, 2003, Volume: 8, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diarrhea; Docetaxel; Drug Hypersensitivity; Feasibility Studies; Female; Humans; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Patient Compliance; Prospective Studies; Severity of Illness Index; Taxoids; Treatment Outcome; Vomiting	2003
Special patients, special treatments. Clinical lung cancer, 2003, Volume: 5, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Fever; Gemcitabine; Health Status; Humans; Lung Neoplasms; Middle Aged; Neutropenia; Population Dynamics; Taxoids	2003
[Effects of docetaxel dosage in combination chemotherapy with carboplatin against advanced non-small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Taxoids	2003
[A clinical study of neoadjuvant radiochemotherapy with docetaxel and cisplatin for oral cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neutropenia; Radiotherapy Dosage; Radiotherapy, Adjuvant; Stomatitis; Taxoids	2003
Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity. American journal of clinical oncology, 2004, Volume: 27, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Taxoids; Treatment Outcome	2004
Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy. Gynecologic oncology, 2004, Volume: 92, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fever; Genital Neoplasms, Female; Humans; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Taxoids	2004
Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:3 Topics: Aged; Alopecia; Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Feasibility Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Taxoids	2004
[Docetaxel and carboplatin for epithelial ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Evaluation; Drug Hypersensitivity; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Neutropenia; Ovarian Neoplasms; Taxoids	2004
[Combination chemotherapy with docetaxel+carboplatin in the treatment of cancer of the ovary and fallopian tube]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Edema; Fallopian Tube Neoplasms; Female; Humans; Leukopenia; Middle Aged; Neutropenia; Ovarian Neoplasms; Peripheral Nervous System Diseases; Taxoids	2004
Relationship of systemic exposure to unbound docetaxel and neutropenia. Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Docetaxel; Female; Humans; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Severity of Illness Index; Taxoids	2005
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment. Urology, 2005, Volume: 65, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alopecia; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Estramustine; Humans; Imidazoles; Life Tables; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Orchiectomy; Pain; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome; Zoledronic Acid	2005
Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:2 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Erythropoietin; Female; Humans; Incidence; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Skin Diseases; Taxoids	2005
Neutropenia and enterocolitis with docetaxel treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, Volume: 7, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Enterocolitis; Female; Humans; Middle Aged; Neutropenia; Taxoids	2005
Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapy. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 49, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytochrome P-450 Enzyme System; Disease Progression; Docetaxel; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Survival Rate; Taxoids; Treatment Outcome	2005
Adjuvant docetaxel for node-positive breast cancer. The New England journal of medicine, 2005, Sep-01, Volume: 353, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Lymphatic Metastasis; Neutropenia; Sepsis; Taxoids	2005
Adjuvant docetaxel for node-positive breast cancer. The New England journal of medicine, 2005, Sep-01, Volume: 353, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Neutropenia; Taxoids	2005
[Neutropenia induced by taxoids and its control with granulocyte colony-stimulating factor]. Investigacion clinica, 2005, Volume: 46, Issue:3 Topics: Antineoplastic Agents; Docetaxel; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia; Paclitaxel; Recombinant Proteins; Retrospective Studies; Taxoids	2005
Life-threatening complications from doxorubicin-docetaxel chemotherapy for breast cancer. JAMA, 2005, Nov-02, Volume: 294, Issue:17 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia; Taxoids	2005
[Weekly docetaxel treatment for head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:12 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neutropenia; Taxoids; Thrombocytopenia	2005
[Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neutropenia; Pilot Projects; Taxoids	2006
Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients. Cancer science, 2006, Volume: 97, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Blood Proteins; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Taxoids	2006
Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim. Oncology, 2006, Volume: 70, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colony-Stimulating Factors; Docetaxel; Epirubicin; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Middle Aged; Neutropenia; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Taxoids	2006
The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:3 Topics: Adult; Aged; Ambulatory Care; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Ciprofloxacin; Clinical Trials, Phase II as Topic; Docetaxel; Doxorubicin; Feasibility Studies; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Japan; Middle Aged; Neoadjuvant Therapy; Neutropenia; Recombinant Proteins; Retrospective Studies; Risk Assessment; Taxoids; Telephone; Treatment Outcome	2007
Population pharmacokinetic-pharmacodynamic model for neutropenia with patient subgroup identification: comparison across anticancer drugs. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Sep-15, Volume: 12, Issue:18 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Drug Interactions; Etoposide; Female; Humans; Liver; Male; Middle Aged; Models, Theoretical; Neutropenia; Neutrophils; Paclitaxel; Sex Characteristics; Taxoids; Topotecan	2006
[Examination of the safety of docetaxel/cyclophosphamide combination therapy for advanced recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:10 Topics: Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Skin Neoplasms; Stomatitis; Taxoids	2006
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1 Topics: Aged; Antineoplastic Agents; Area Under Curve; Cytochrome P-450 CYP3A; Docetaxel; Female; Ferritins; Humans; Lymphocyte Count; Male; Midazolam; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Radiation-Sensitizing Agents; Risk Factors; Taxoids	2007
A prospective investigation of chemotherapy-induced neutropenia and quality of life. The journal of supportive oncology, 2006, Volume: 4, Issue:9 Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Cisplatin; Cyclophosphamide; Depression; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Prednisone; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quality of Life; Regression Analysis; Severity of Illness Index; Sickness Impact Profile; Taxoids; Treatment Outcome; United States; Vincristine	2006
[Docetaxel combined with cisplatin in the treatment of anthracycline-resistant advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:6 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Neutropenia; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome; Vomiting	2006
The preliminary results of docetaxel-prednisolone combination therapy for the Japanese patients with hormone-refractory prostate cancer. Hinyokika kiyo. Acta urologica Japonica, 2007, Volume: 53, Issue:2 Topics: Administration, Oral; Aged; Ambulatory Care; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Feasibility Studies; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids	2007
[Outpatient chemotherapy for lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:4 Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gefitinib; Gemcitabine; Humans; Informed Consent; Irinotecan; Lung Neoplasms; Neutropenia; Paclitaxel; Quality of Life; Quinazolines; Taxoids; Vinblastine; Vinorelbine	2007
Docetaxel and cisplatin as second-line chemotherapy for advanced non-small cell lung cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Taxoids	2007
[Dose dense chemotherapy in the postoperative adjuvant treatment for breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Nausea; Neutropenia; Paclitaxel; Postoperative Period; Retrospective Studies; Taxoids	2007
Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients. Cancer science, 2007, Volume: 98, Issue:12 Topics: Adult; Antineoplastic Agents; Docetaxel; Humans; Infusions, Intravenous; Japan; Kinetics; Models, Biological; Neoplasms; Neutropenia; Reproducibility of Results; Taxoids	2007
Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis. British journal of cancer, 2007, Dec-17, Volume: 97, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Epirubicin; Feasibility Studies; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Retrospective Studies; Taxoids	2007
Logistic regression analysis for febrile neutropenia (FN) induced by docetaxel in Japanese cancer patients. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Data Interpretation, Statistical; Docetaxel; Female; Fever; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Taxoids	2008
The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 60, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	2008
Measuring the cost of chemotherapy is important, but it is not enough. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Complementary Therapies; Cost of Illness; Cost-Benefit Analysis; Docetaxel; Drug Costs; Humans; Neutropenia; Paclitaxel; Quality of Life; Quality-Adjusted Life Years; Survival Analysis; Taxoids; Therapies, Investigational	2008
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer science, 2008, Volume: 99, Issue:5 Topics: Antineoplastic Agents; Constitutive Androstane Receptor; Docetaxel; Genotype; Humans; Leukopenia; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neutropenia; Organic Anion Transporters, Sodium-Independent; Polymorphism, Genetic; Solute Carrier Organic Anion Transporter Family Member 1B3; Taxoids	2008
Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Japan; Mastectomy; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Taxoids	2008
Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 62, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clinical Trials as Topic; Deoxycytidine; Disease Progression; Docetaxel; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Time Factors; Treatment Outcome	2008
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer. Australian and New Zealand journal of medicine, 1997, Volume: 27, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Ascites; Breast Neoplasms; Docetaxel; Edema; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pleural Effusion; Taxoids; Treatment Failure; Treatment Outcome	1997
[Advance through research]. Der Internist, 1994, Volume: 35, Issue:8 Suppl Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Docetaxel; Dose-Response Relationship, Drug; Drug Therapy; Humans; Neutropenia; Paclitaxel; Research; Taxoids	1994
Docetaxel is a potent cytotoxic drug in the treatment of advanced breast cancer. Acta clinica Belgica, 1998, Volume: 53, Issue:4 Topics: Adult; Aged; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Division; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Microtubules; Middle Aged; Mitosis; Neoplasm Staging; Neutropenia; Paclitaxel; Remission Induction; Survival Rate; Taxoids; Tubulin	1998
Docetaxel: response in patients who have received at least two prior chemotherapy regimens for metastatic breast cancer. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Taxoids; Treatment Outcome	1998
Continual reassessment methods in phase I trials of the combination of two drugs in oncology. Statistics in medicine, 1999, Jul-30, Volume: 18, Issue:14 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Camptothecin; Clinical Trials, Phase I as Topic; Computer Simulation; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Humans; Irinotecan; Likelihood Functions; Neoplasms; Neutropenia; Paclitaxel; Retrospective Studies; Taxoids	1999
A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy. Journal of hematotherapy & stem cell research, 1999, Volume: 8, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cells, Cultured; Culture Media, Serum-Free; Cyclophosphamide; Dendritic Cells; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-4; Leukapheresis; Leukocyte Count; Lymphocyte Culture Test, Mixed; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neutropenia; Paclitaxel; Taxoids	1999
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Squamous Cell; Docetaxel; Enterocolitis; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Taxoids; Tomography, X-Ray Computed	2000
Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis. Cancer, 2000, Sep-15, Volume: 89, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Docetaxel; Female; Humans; Immunophenotyping; Infections; Lymphocyte Count; Lymphocyte Subsets; Lymphocytes; Lymphopenia; Male; Middle Aged; Neoplasms; Neutropenia; Neutrophils; Paclitaxel; Prospective Studies; Taxoids	2000
[Effect of G-CSF (nartograstim) on neutropenia (leukopenia) induced by taxane in metastatic breast cancer--time-course changes in neutrophil and leukocyte counts]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Neutropenia; Neutrophils; Paclitaxel; Retrospective Studies; Taxoids	2001
Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Therapy, Combination; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infection Control; Infections; Inflammation; Melphalan; Middle Aged; Mitoxantrone; Mucous Membrane; Multivariate Analysis; Neutropenia; Paclitaxel; Patient Selection; Retrospective Studies; Risk; Taxoids; Thiotepa; Transplantation Conditioning	2001
Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13 Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Eruptions; Female; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Paclitaxel; Salvage Therapy; Taxoids; Treatment Outcome	2002